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ABSTRACT
PROTEIN PHOSPHORYLATION AND DEPHOSPHORYLATION
IN THE PARIETAL CELL:
THE ROLE OF THE REGULATORY SUBUNIT
OF TYPE II CYCLIC AMP-DEPENDENT PROTEIN KINASE
IN HISTAMINE-STIMULATED ACID SECRETION
Valerie Anne Asher
1990
The role of cAMP in mediating histamine-stimulated parietal cell secretion
is well established. Traditional views have suggested that the actions of cAMP are
mediated through the activation of cAMP-dependent protein kinase (CAPK). The
data presented here suggest a new model for cAMP-mediated acid secretion in
which dephosphorylation of the regulatory subunit of Type II CAPK (Rll) plays a
critical role.
Isolated rabbit parietal cells (85 ± 5% pure) were incubated with either 100
AiM cimetidine (unstimulated) or a combination of 100 /xM histamine and 10 juM
forskolin (maximally stimulated) for 45 min. The cells were then homogenized and
subcellular fractions were prepared to localize phosphorylation changes to specific
intracellular compartments. Differential centrifugation at 40xg, 4000xg, 14,500xg,
and 48,500xg was used to prepare the subcellular fractions which were then
characterized and assayed for endogenous kinase activity using [gamma-32P]-ATP
as a phosphate donor. Phosphorylated proteins were then resolved using SDSPAGE and autoradiography.
A 52 kDa protein (pp52) was found to be phosphorylated in the stimulated
apical membrane fraction and the unstimulated cytosolic fraction. This activity was

extremely rapid; pp52 was 100% phosphorylated within 45 sec. The kinase was
dependent on Mg2+ and ATP (Ky, 3 ^M) but could also use GTP as a phosphate
donor (K,/? 10 /uM). The addition of 10

cAMP to protein samples from stimulated

apical membrane fractions abolished the phosphorylation of pp52. This inhibitory
effect of cAMP was found to be due to the presence of a membrane-associated
phosphatase activity that completely dephosphorylated pp52 within 120 sec.
Although this phosphatase activity was not inhibited by Zn2+,

Mn2+, pyrophos¬

phate, or NaF, it was inhibited by the phosphatase inhibitor okadaic acid, at a
concentration that suggested it was mediated by a Type 1

phosphatase.

Isoelectric focusing, phosphoamino acid analysis, cAMP-binding studies, and
immunoprecipitation identified the 52 kDa proteins in both membrane and cytosol
as the regulatory subunit of Type II CAPK. Immunoprecipitation also suggested
that the proteins found in membrane and cytosol were two different subtypes of
Rll.
Whole cell secretion studies also supported the hypothesis that a
phosphatase plays a critical role in histamine-stimulated acid secretion. Histaminestimulated [14C]aminopyrine ([14C]AP) uptake was measured in isolated rabbit
parietal cells in the presence and absence of okadaic acid. Okadaic acid inhibited
histamine-stimulated [14C]AP uptake with an ID^ of approximately 10 juM.

In

contrast, H-8, an inhibitor of CAPK did not affect histamine-stimulated [,4C]AP
uptake, suggesting the CAPK may not play a major role in histamine-stimulated
acid secretion. These results suggest that the histamine-stimulated increase in
cAMP may stimulate processes other than activation of cAMP-dependent protein
kinase.
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INTRODUCTION
While the formation of gastric and duodenal ulcers is probably determined
by the balance between destructive and protective factors, it has often been
observed that ulcers are seen only in the presence of acid. Thus the control of
acid secretion is of considerable interest in the treatment of ulcer disease.
However the mechanism of acid secretion is still poorly understood; thus drug
therapies have been directed primarily at the first and last steps in acid secretion.
The first step in acid secretion involves hormone-receptor interactions at the
cell surface. Known stimuli of acid secretion include histamine, acetylcholine, and
gastrin. The Type II histamine (H2) antagonists competitively bind to histamine
receptors on the cell surface, thus preventing the endogenous secretagogue from
initiating acid secretion. Because the various pathways that lead to acid secretion
are interdependent, these drugs also decrease the amount of acid secreted in
response to gastrin and cholinergic agents1.

Anticholinergic drugs such as

atropine work in a similar fashion to decrease gastric acid secretion. However,
because of their serious side effects, more specific antimuscarinics such as the Ml
antagonist pirenzapine are preferable2, though less efficacious. The final step in
acid secretion is the actual secretion of protons.

Omeprazole, a substituted

benzimidazole, specifically inhibits the H"/K'-ATPase that is ultimately responsible
for pumping protons into the lumen of the stomach2.
While the H2 receptor blockers have made the treatment of peptic ulcer
disease far more effective, some forms of gastric and duodenal ulceration, such
as the stress ulcers sometimes seen in patients with shock, burns, sepsis, or
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trauma, may not be amenable to conventional medical therapies3. This may reflect
the fact that agents other than acid, such as pepsin, may be involved. However,
a better understanding of the cellular physiology of acid secretion might enable us
to treat such patients more effectively.

In order to do this the molecular

mechanism of acid secretion must be defined and the subcellular regulatory
pathways delineated. This project represents an attempt to illuminate this area by
examining the role of protein phosphorylation in the secretion of acid by the
parietal cell.
The secretagogues that stimulate acid secretion also stimulate a number of
so-called "second messengers," suggesting that several convergent pathways
control acid secretion.

These second messengers, such as cyclic adenosine

3' :5'-monophosphate (cAMP) and calcium, are thought to regulate intracellular
processes by activating protein kinases and phosphatases. These enzymes alter
the activities of essential protein substrates by adding or removing phosphate
groups. It is therefore reasonable to postulate that the phosphorylation state of a
key substrate may play a role in the control of acid secretion.
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CHAPTER ONE
ACID SECRETION IN PERSPECTIVE
THE STOMACH
While the work presented here has focused on gastric acid secretion, the
stomach serves many functions. Muscular walls allow it to expand and act as a
reservoir for food, while peristaltic contractions serve to mix chyme with gastric
secretions and to empty the gastric contents into the duodenum. The stomach is
also an endocrine organ, for the antral mucosa contains G-cells that produce
gastrins, a group of hormones that stimulates acid and pepsinogen secretion,
gastric and intestinal motility, increased pressure in the lower esophageal
sphincter, and bicarbonate secretion by the pancreas and liver.

The exocrine

secretions of the stomach include HCI, pepsinogen, intrinsic factor, and mucus.
The secretion of gastric acid lowers the pH of the gastric contents.

This

acidification serves several purposes. Gastric HCI may sterilize the contents of the
stomach. It also promotes the conversion of pepsinogen to pepsin and provides
the low pH necessary for pepsin to catalyze the breakdown of proteins.

ACID SECRETION: HISTORY
Given the complexity of gastric function, it is not surprising that the study of
gastric acid secretion has been enmeshed in controversy. In the past, scientists
disagreed about whether the stomach secreted acid and if so, which acid it
produced. Only recently has the parietal cell been identified as the site of acid
production. Thus it now remains to identify the intracellular processes that mediate
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gastric HCI secretion.
The history of the study of acid secretion has been extensively reviewed in
an excellent review article by Modlin and is briefly summarized here4. Early Greek
theories of digestion recognized neither the role of the stomach nor the function
of acid in digestion. Not until the sixteenth century did Paracelsus assert that the
stomach contains acid and that it is necessary for digestion. He believed that by
drinking acidic spa waters one introduced acid into the stomach. Jean Baptiste von
Helmont and Sylvius also held to this chemical theory of digestion but did little to
further understanding of the nature or source of gastric acid. Indeed von Helmont
believed the spleen to be the source, while Sylvius maintained that the digestive
processes of the stomach were mediated by saliva. These contradictory chemical
theories were coi;ectively challenged by a second school of thought that main¬
tained that the stomach’s main function was mechanical.
In the eighteenth century, experimental science blossomed, and inves¬
tigators such as Reaumur, Reuss, Gosse, Stevens, Spallanzani, Scopoli and
Carminati studied digestion and the contents of the stomach in both humans and
animals. Scopoli and Spallanzani produced evidence to suggest that the stomach
contained hydrochloric acid. This was confirmed definitively by William Prout in
1823, when he presented his paper "On the Nature of Acid and Saline Matters
Usually Existing in the Stomach of Animals" to the Royal Society of London. In this
work he showed evidence that hydrochloric acid is found in the gastric juice of
many different species. He was also able to quantify his data, showing the total
amount of hydrochloric acid present and relating it to dyspeptic symptoms. This
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work predated that of William Beaumont, who published his first experiments in
1826. Nonetheless, complete acceptance of Prout’s theory did not come until this
century. Various investigators attempted to show that acetic, butyric, lactic, and
phosphoric acids were secreted by the stomach. Not until 1930 did Dodds and
Robertson confirm that hydrochloric acid was the sole acid produced by the
stomach.
Beginning with Pavlov’s studies on vagal control of gastric secretion,
scientists began to investigate neural control of acid secretion. At the same time
other researchers began to elucidate the humoral regulation of the gastrointestinal
tract, identifying both histamine and gastrin as important regulators of gastric acid
production. However the exact source of gastric acid remained unknown.
At the beginning of the nineteenth century Matthias Schleiden and Thomas
Schwann opened the world of cell biology with the theory that all life is composed
of cells. Over the next century, the different gastric cell types, including the parietal
cell, were identified. The parietal cell took its name from the Latin word for wall,
based on its tendency to bulge outward from the wall of the gastric gland5. It is
now also known as the oxyntic cell, a name given because of its ability to produce
acid5. The morphology of the parietal cell was described, with its numerous, large
mitochondria, cytoplasmic tubulovesicles, and extensive invaginations of the apical
membrane known as "intracellular" canaliculi despite their apparent continuity with
the gland lumen8.
In 1858, Claude Bernard used chemical and microscopic methods in an
attempt to determine the site of acid formation.

Using a precursor of Prussian
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blue, a colored pH indicator, he injected rabbits, then removed their stomachs for
microscopic examination. He found the blue color indicative of low pH only in the
superficial layer of the mucosa; it stained neither the gastric glands nor the canaliculi of the parietal cell.

Mistakenly, he took this as evidence that the stomach

secreted a neutral substance that underwent further reaction to become acidic
within the lumen of the stomach7.
Later investigators found circumstantial evidence to suggest that the parietal
cell was indeed the source of gastric HCI. Acid is found only in stomachs that
contain parietal cells, and the amount produced is proportional to the number of
parietal cells present58. The presence of acid in the fetal stomach was also found
to be temporally related to parietal cell differentiation9. The unique morphology of
the parietal cell seemed well suited for this purpose, with its abundant, large
mitochondria to provide energy and its extensive, dynamic system of canaliculi.
These were believed to be a secretory apparatus that cycled between the resting
and the stimulated states. A number of investigators looked for further evidence
that the parietal cell was the source of gastric acid. Bradford and Davies used 26
pH indicator dyes to study isolated amphibian and mammalian gastric mucosa.
They found that in histamine-stimulated tissue, the contents of the intracellular
canaliculi had a pH of less than 4.85,10. Kominick used silver to precipitate chlo¬
ride and found precipitates in the glandular lumen and vesicles of parietal cells.
This physical proximity was taken as further evidence that parietal cells are the
source of gastric HCI5. Later studies looked at isolated rabbit gastric glands with
interference, electron, and fluorescence microscopy. Parietal cells in histamine-
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stimulated gastric glands formed intracellular spaces consistent with the expanded
canalicular network previously described in stimulated cells. The use of the pHdependent fluorescent indicator acridine orange confirmed that the spaces were
indeed acidic11,12. Another line of investigation developed when HCI secretion was
found to be dependent on a mechanism requiring ATP and K+: the HT/K'-ATPase.
A monoclonal antibody developed against the catalytic subunit of this enzyme
recognized only one kind of cell in the gastric mucosa, the parietal cell13. This
provided substantial support for the theory that the parietal cell is the source of
gastric acid.

PARIETAL CELL MORPHOLOGY
The simple columnar epithelium that lines the

mammalian stomach is

interrupted by gastric pits, invaginations of the mucosa that lead to one or more
tubular gastric glands. The gastric glands of the fundus and corpus, known as
oxyntic glands, contain several types of cells: the oxyntic or parietal cell, the chief
cell, the mucus neck cell, as well as endocrine cells (Figure 1). The parietal cell
is the most numerous cell of the corpus, making up about 32% of the corpus
mucosa5. The normal human stomach contains approximately one billion parietal
cells9. They are usually found in the neck and isthmus regions of the oxyntic gland
but can also be found along the base.
The parietal cell is an oval to pyramidal cell that may be as large as 25 /xM.
Several features make it morphologically distinctive5. First, it contains abundant,
large mitochondria to provide the energy necessary for the proton pump. Second,
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FIGURE 1: The gastric aland.
Simplified drawing of a tubular gastric gland from the corpus of a mammalian
stomach showing the basic cell types: mucous neck cells, parietal cells, chief cells,
and parietal cells. Parietal cells are concentrated in the neck and isthmus of the
gland, although they are also found along the base. (Adapted from ref. 5).
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in the resting state, the cytoplasm is filled with smooth, membranous tubulovesicular structures (Figure 2).

Lastly, the cell is penetrated by canalicuii that are

continuous with the apical membrane of the cell and communicate with the oxyntic
gland lumen. In the unstimulated cell, the canalicuii are quite small and possess
short, stubby microvilli as does the apical membrane of the cell. When the parietal
cell is stimulated with secretagogues that promote acid secretion, the canalicular
system expands and the microvilli grow longer and more numerous, increasing the
apical surface area by a factor of four or more. At the same time the tubulovesicular membranes disappear from the cytoplasm (Figure 2). When secretion stops,
the microvilli of the canalicular system return to their original state, while the tubulovesicles reappear in the cytoplasm14,5. Morphometric studies have shown that the
increase in the apical surface area corresponds to a decrease in that of the
tubulovesicles15.
Two

hypotheses

have

attempted

to

explain

these

morphological

changes16,17,18. The osmotic flow or expansion hypothesis contends that the tubulovesicular membranes are continuous with the apical membrane but that in the
resting cell the tubulovesicles are supercollapsed. They expand in response to net
ionic and volume flow, thus creating the apparent structural changes in the cell.
However experiments that induced the accumulation of water and salt within
tubulovesicles did not lead to enlargement of the apical membrane17. It therefore
seemed that osmotic change alone was not sufficient to bring about the
morphological changes associated with secretion. No further data has been pro¬
duced in support of the osmotic flow theory.
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FIGURE 2: Electron micrographs of resting and histamine-stimulated parietal
cells.
Electron micrographs (10,000 x magnification) were prepared from isolated rabbit
parietal cells prepared as described in Chapter 3. Histamine-stimulated cells were
incubated with 10 mM histamine for 45 min. In the resting parietal cell (A),
numerous tubulovesicles fill the cytoplasm. Large numbers of mitochondria are
also present. In the stimulated parietal cell (B), the tubulovesicles have disappeared
from the cytoplasm and the canalicular network has become more elaborate.
(Electron micrographs courtesy of Dr. James Goldenring, Yale University, New
Haven, CT).
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Far more credible is the membrane recycling or fusion hypothesis, which
proposes that the tubulovesicles fuse with the apical membrane upon stimulation
of the cell. When the cell returns to the resting state these membranes are some¬
how retrieved to form tubulovesicles19.

Several pieces of evidence support this

theory. Antibodies directed against the H+/K+-ATPase localized the enzyme to the
tubulovesicles of the resting cell, with less of the enzyme being found in the apical
membrane. In contrast, in the stimulated cell, the H+/K+-ATPase was predominately
found in the apical membrane13, suggesting that the movement of the IT/HCATPase depends upon the fusion of tubulovesicles with the apical membrane.
Freeze-fracture electron microscopy has also shown that upon histamine
stimulation, the particle distribution of the apical membrane changes, becoming
more like that of the tubulovesicles19. This suggests that the tubulovesicular
membrane has become part of the apical surface. Other studies of fixed cells with
macromolecular tracers or extracellular surface stains have failed to show any
direct communication between the cell surface and the tubulovesicles. However
when macromolecular tracers were incubated with living cells, prior to fixation, they
showed up within the tubulovesicles16. This is consistent with the fusion hypothesis
in that there is no direct communication between the cell surface and tubulo¬
vesicles, but that a pathway does exist for the movement of materials between the
apical membrane and the tubulovesicles.
Changes in the cytoskeletal architecture of the parietal cell parallel the
changes in membrane structure. Actin-like filaments are found in the microvilli,
while other studies have shown microfilaments and microtubules beneath the
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microvilli20,14

Double labelling of cells with antibodies against actin and spectrin

showed striking evidence of carbachol-stimulated cytoskeletal reorganization cor¬
responding to changes in the membrane structure of stimulated cells21. Disruption
of actin filaments and microtubules also disrupts parietal cell function. When cytochalasin, a drug which prevents the elongation of actin filaments, is added to piglet
mucosa, acid secretion is inhibited22. Similarly, when guinea pig parietal cells were
treated with colchicine and vinblastine, histamine-stimulated acid production was
impaired23. These data suggest that cytoskeletal elements may mediate both the
fusion of tubulovesicles with the apical membrane in the stimulated cell and their
retrieval when the cell returns to the resting state.

PARIETAL CELL PHYSIOLOGY
Methods of study
in vivo a number of stimuli cause gastric acid secretion: the sight, taste,
smell and thought of food, gastric distention, proteins and amino acids in the
stomach, chyme in the duodenum, vagal stimulation, acetylcholine, histamine, and
gastrin24.

Because of the complexity of this system, neither in vivo studies nor

those using intact gastric mucosa shed much light on the direct effectors of
parietal cell acid secretion.

For this purpose, cell separation techniques, using

enzymatic digestion and centrifugation, have been developed to facilitate the study
of viable gastric glands25 and isolated gastric cells. Because of the large size of
the parietal cell, techniques such as counterflow elutriation and centrifugation on
density gradients can be used to prepare cells that are up to 90% pure26. More
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recently a procedure has been developed that allows the culture of highly enriched
parietal cells, making long-term studies feasible for the first time27.
Studies of dispersed gastric glands and cells have one important disad¬
vantage. With the loss of mucosal polarity, it is no longer possible to measure
proton secretion directly, since the basolateral membrane secretes a neutralizing
bicarbonate ion26. Therefore indirect methods have been developed to permit the
study of parietal cell function in vitro11,26,28.
The energy requirements of the parietal cell provide one way to assess
secretory activity. The HT/K -ATPase, the proton pump, requires ATP. This ATP
is provided by the abundant mitochondria that occupy 30 to 40% of the parietal
cell cytoplasm.

In order to produce ATP, the mitochondria consume oxygen.

Thus oxygen consumption provides an indirect measure of secretory activity. A
similar protocol measures the formation of 14C02 from [14C] glucose to determine
metabolic activity26.
Another measure of secretory activity makes use of the profound
morphologic transformation of the stimulated parietal cell. This change can be
observed in living ceils using either differential interference-contrast microscopy
(Nomarski optics) or fluorescent microscopy. The latter can be used with acridine
orange, a weak base that accumulates in acidic spaces and emits a red
fluorescence at low pH11,26.
The tendency of weak bases to accumulate in membrane-bound acidic
spaces is also used in another method.

A radioactive weak base such as

[14C]aminopyrine ([14C]AP), which has a pKa of 6, will accumulate in the acidic
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spaces of actively secreting parietal cells.

Acid sequestration can be quantified

by simply measuring the radioactivity that remains associated with washed parie¬
tal cells after incubation with [14C]AP2628. This method is probably the most widely
used in the study of parietal cell secretory activity.
While these methods have helped to overcome one problem encountered
in the study of acid secretion, others exist that are not so easily solved.
Particularly troubling are the variations in parietal cell function found among dif¬
ferent species.

For example, in some mammalian species, including rabbit and

man, the parietal cell secretes intrinsic factor (IF) as well as HCI29, whereas in other
species the chief cell is responsible for secreting IF. In nonmammalian vertebrates,
a single cell type, the oxyntopeptic cell secretes both pepsinogen and acid5. It has
therefore been difficult to establish whether there exists a generalized mechanism
of acid secretion with some minor variations between species.

However most

reports support a common mechanism of receptor-mediated proton secretion
effected by the H7K+-ATPase proton pump.

The regulation of acid secretion in vivo
in vivo studies show that paracrine, neurocrine. and endocrine pathways
influence gastric acid secretion. When the isolated gastric gland or parietal cell is
studied in vitro, these pathways appear to correspond to three recognized secretagogues: histamine, acetylcholine, and gastrin (Figure 3). Histamine is found in
the mast cells of the gastric mucosa, although it is possible that a second cell
type in the gastric mucosa also produces histamine. The parasympathetic nerve
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H
FIGURE 3: Regulatory pathways of the parietal cell.
Histamine, acetylcholine, and gastrin appear to stimulate the parietal cell; however
gastrin receptors have been demonstrated only on canine parietal cells. In other
species gastrin may act indirectly by stimulating the release of histamine. It is not
yet clear which cell type in the gastric mucosa is the source of histamine. N neuron; X - histamine-producing cell; GC - G cell; Ach - acetylcholine; H histamine; G - gastrin.
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terminals release acetylcholine.

Gastrin, a peptide hormone, is released by the

gastric endocrine G cells.

Histamine stimulation of acid secretion
There is a large body of evidence to support the assertion that histamine
stimulates gastric acid secretion.

Berglindh et ak25'28 first showed that histamine

stimulated oxygen consumption and [14C]aminopyrine uptake in a dose-dependent
fashion in isolated rabbit glands with an ED50 of 3 x 106M, reaching a maximum
after about 30 minutes. Histamine stimulation of parietal cells has also been
demonstrated in cells from many other species, including pig30, dog31, rat32, guinea
pig33, frog26, and human34. However there are differences between species in the
magnitude of the response to secretagogue35. For example histamine-stimulated
[14C]aminopyrine uptake is greater in rabbit parietal cells than in those of the dog26.
The response to histamine appears to be mediated through a typical H2 receptor.
The H2 receptor antagonist cimetidine was found to be a competitive inhibitor of
histamine-stimulated rabbit gastric gland secretion36.

While the H, receptor an¬

tagonist mepyramine successfully inhibited histamine-stimulated [14C]aminopyrine
accumulation in canine cells, it did so at a concentration 105 times higher than that
required for H, receptor blockade31. Thus histamine and its antagonists appear to
act through an H2 receptor.
Histamine stimulation of parietal cells also increases the concentration of
cyclic adenosine monophosphate (cAMP) in many species, including rabbit36 and
dog37. This was enhanced in the presence of the phosphodiesterase inhibitor 3-
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isobutyl-1 -methyl xanthine (IBMX)38. Several facts indicate the involvement of cAMP
in parietal cell acid secretion. First, the increase in cAMP correlated with histamine
stimulation of parietal cell function as measured by oxygen consumption and
[14C]aminopyrine accumulation38.

Second, the action of histamine can be en¬

hanced by the use of IBMX, which prevents the degradation of cAMP by cAMP
phosphodiesterase26. Third, the use of forskolin, a specific activator of adenylate
cyclase, the enzyme that converts ATP to cAMP, increases both parietal cell
activity and intracellular cAMP39.

Lastly, the use of the cell-permeant cAMP

analogues dibutyryl cAMP (DBcAMP) and 8-bromo-cAMP directly stimulate
[14C]aminopyrine accumulation in isolated canine parietal cells31.
While the study of histamine-stimulated parietal cell activity has focused on
the role of cAMP, a second system may also play a part.

Studies using the

calcium-sensitive dyes quin2 and fura-2 have shown that histamine causes an
increase in the intracellular calcium ([Ca],)40 41 .

Histamine stimulation led to a

calcium spike within 5 seconds followed by a plateau level that persisted until the
removal of agonist or the addition of antagonist.

The H2 receptor antagonist

cimetidine specifically blocked this reaction. This increase does not appear to be
mediated by cAMP, since addition of DBcAMP and IBMX did not affect the intracel¬
lular calcium concentration42 43. However forskolin was found to increase cytosolic
free Ca2+ in rabbit gastric glands40 and pig parietal cells30. The calcium spike oc¬
curred in the presence of calcium channel blockers. Thus it seems to represent
the release of calcium from an intracellular store.

In contrast, the plateau that

appears after the spike appears to depend on the influx of extracellular calcium
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across the plasma membrane43. The role of the Ca2+ signal in histamine-stimulated
acid secretion is unclear since chelation of neither extracellular 43 44 nor intracel¬
lular44 Ca2+ affected histamine-stimulated uptake of [14C]aminopyrine in rabbit parie¬
tal cells.

Cholinergic stimulation of acid secretion
Cholinergic agonists such as carbachol have also been shown to affect
parietal cell secretory activity45 23. When carbachol was added to isolated rabbit
glands, oxygen consumption, a marker for acid secretion, increased, reaching a
maximum at 15 to 20 minutes and slowly declining from that point28. This is in
marked contrast to the pattern seen with histamine stimulation, where peak parietal
cell activity is sustained at a maximal plateau.

The secretory response to

carbachol in rabbit glands is also weaker than that seen with histamine28. Some
differences exist between species.

In canine parietal cells, carbachol stimulates

a sustained response that is greater than that of either histamine or gastrin3'. The
specificity of the response to cholinergic agonists has been shown by the fact that
it is competitively inhibited by atropine but unaffected by the H2 receptor blocker
cimetidine31.
Carbachol appears to act independently of cAMP. The stimulatory effect is
seen without a corresponding increase in intracellular cAMP38.
histamine,

However, like

carbachol stimulates an increase in the intracellular calcium con¬

centration of the parietal cell. This increase can be blocked by the muscarinic
antagonist atropine43. The addition of carbachol leads to the efflux of calcium from
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intracellular stores, causing a calcium ipike followed by a plateau phase that
seems to depend on the influx of extracellular calcium43.

Because of calcium’s

known role as a second messenger46, it is tempting to speculate that it plays a role
in acid secretion. However it has been difficult to prove this connection. It has not
been possible to use Ca2+ ionophores to study parietal cell proton secretion,
because they also interfere with H+ concentrations and thereby impair function of
the proton pump47. However there is some data to suggest that calcium does play
a part in acid secretion. In medium with a low concentration of Ca2’ (10 5M) aminopyrine accumulation by acetylcholine-stimulated rabbit gastric glands is decreased
by 70%42.

Even more convincing is the fact that use of an intracellular calcium

chelator (1,2-Bis(2aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid acetoxy methyl
ester) eliminated both the carbachol-stimulated calcium signal and carbacholstimulated [14C]aminopyrine accumulation in rabbit parietal cells44.

Gastrin stimulation of acid secretion
The role of gastrin in stimulating parietal cell acid secretion is somewhat less
clear than that of histamine or cholinergic agonists. Gastrin receptors have been
demonstrated only on canine parietal cells using 125l-gastrin as a probe48.

In

addition, parietal cells from different species respond very differently to gastrin.
When first studied in isolated rabbit gastric glands, gastrin failed to induce in¬
creased

respiratory

activity,

increased

quantifiable changes in morphology28.

[14C]aminopyrine

accumulation,

or

Subsequent studies of isolated canine

parietal cells showed a small increase in parietal cell activity with gastrin stimula-
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tion. Neither atropine nor cimetidine blocked this response, suggesting that it was
mediated through a third receptor that was neither cholinergic nor histaminergic31.
Proglumide, an inhibitor of cholecystokinin, inhibits the effect of gastrin on parietal
cells but does not appear to affect responses mediated by other receptor types48.
This probably reflects the fact that cholecystokinin, a peptide hormone, shares a
common tetrapeptide sequence with gastrin at the carboxyl terminal.

Gastrin-

stimulation of [14C]aminopyrine accumulation was seen when rabbit gastric glands
were treated with the phosphodiesterase inhibitor IBMX or the sulfhydryl reducing
agent dithiothreitol (DTT). This response was inhibited by cimetidine49. jQ-Mercaptoethanol, which enhances the histamine sensitivity of the rabbit parietal cell, also
enhanced the gastrin response26. Since gastrin is known to release histamine from
gastric glands, it is possible that its effects on the rabbit parietal cell are mediated
by histamine and not by the direct effect on the parietal cell that has been noted
in the dog26.
While there are several different regulatory pathways modulating parietal cell
stimulatory activity, they are clearly interdependent.

Histamine, carbachol, and

gastrin potentiate one another’s actions, producing effects that are greater than the
sum of their effects alone50,51.

Forskolin, which increases the concentration of

cAMP by activating adenylate cyclase, also potentiates the effect of carbachol40,
as does the cell-permeant cAMP analogue DBcAMP52.

This suggests that the

potentiating effects of secretagogues are mediated within the cell and not at the
level of the receptor.
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Inhibitors of acid secretion
In considering parietal cell physiology, it is also important to note inhibitors
of parietal cell function.

The competitive muscarinic and H2 antagonists have

already been mentioned, as has omeprazole, the H+/K+-ATPase inhibitor, which
is a noncompetitive inhibitor of all parietal cell secretagogues. The prostaglandins
PGE2 and PGI2 inhibit histamine-stimulated parietal cell function53 as well as the
histamine-stimulated increase in cAMP37,54 55 56. Somatostatin also acts noncompetitively to inhibit histamine- and gastrin-stimulated acid secretion in rabbit, rat, and
guinea pig parietal cells56 57 58.

Specific somatostatin receptors have also been

identified on canine parietal cells59.
stimulated increase in cAMP.

Somatostatin also inhibits the histamine-

It is possible that somatostatin acts by inhibiting

adenylate cyclase60. Pancreastatin, a peptide hormone that shares some sequence
homology with gastrin, inhibits both histamine- and carbachol-stimulated aminopyrine uptake in rabbit parietal cells61. While pancreastatin inhibited the histaminestimulated increase in cAMP, it had no effect on the carbachol induced calcium
spike61. The available data suggest that pancreastatin acts to inhibit parietal cell
signal transduction at several different points61. The inhibitory effects of epidermal
growth factor (EGF) have also been described and are equally complex.

EGF

inhibits both histamine- and carbachol-stimulated aminopyrine uptake in isolated
rabbit parietal cells62,63,64. Like pancreastatin, it seems to exert its effect at multiple
points in the signal transduction pathway63.
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PROTEIN KINASES AND PROTEIN PHOSPHORYLATION IN THE PARIETAL
CELL
Stimuli of gastric parietal cell HCI secretion are also known to increase
intracellular concentrations of cAMP and Ca2+.

In many systems these "second

messengers" activate cellular enzymes known as protein kinases. Protein kinases
are able to phosphorylate other proteins. The addition of a phosphate group to
many proteins alters their biological activities. This mechanism is thought to play
a role in regulating a wide variety of cellular processes85. Many investigators have
therefore tried to delineate the role of protein kinases and protein phosphorylation
in parietal cell acid secretion (Tables I and II.)

Protein kinases
Studies focusing on the role of cAMP in the parietal cell have concentrated
on the cAMP-dependent protein kinase (CAPK). This kinase is a tetramer made
of two identical regulatory subunits (R) and two identical catalytic subunits (C)
(Figure 4).
subunit.

In the inactive form, the regulatory subunit is bound to the catalytic

When cAMP is bound to the regulatory subunit, the tetramer disas¬

sociates and the two catalytic subunits are released as the active enzyme. There
are two types of CAPK, known as Type I and Type II. These differ only in the
regulatory subunit; the catalytic subunit is the same for both Type I and Type II
CAPK.
Using isolated rabbit gastric glands Jackson et aL66 identified two cytosolic
cAMP binding proteins with molecular weights of 48 kDa and 58 kDa. These were
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SOURCE

INTRACELLULAR
LOCATION

KINASE

cytosol

cAMP dependent
(unaffected by K+)

membrane

cAMP dependent
(decreased by K+)

cytosol

Zn2+/Mn2+
dependent

cytosol, membrane

cAMP dependent

Rabbit PC

cytosol

Calmodulin
dependent

Rabbit PC

?

Ca2+/phospholipid
dependent (PKC)

Rabbit FGM

STIMULUS

-

Rabbit GG

Rabbit PC

-

Rabbit PC

-

?

2 Casein Kinases

Rabbit PC

histamine

cytosol

cAMP dependent
(type 1)

Guinea Pig FGM

histamine

cytosol

cAMP dependent

Rabbit PC

forskolin

cytosol, membranes

cAMP dependent
(type II)

Rabbit PC

carbachol

?

Ca2+ dependent
PKC

membrane

Ca^+/Calmodulin
dependent

Rat FGM

TABLE I: Protein kinases found in gastric tissue and parietal cells.
For references, see text. Abbreviations: FGM - fundic gastric mucosa;
gastric glands; PC - parietal cells; PKC - protein kinase C.

GG -
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SOURCE

SECRETAGOGUE

KINASE
DEPENDENCE

INTRACELLULAR
LOCATION

SUBSTRATE
PROTEINS

cytosol

148, 130, 47,
43 kDa

membrane

130, 51, 47
kDa

cytosol

many,
esp.131,
97,84, 47,
42, 33 kDa

membrane

many, esp
130, 42, 20,
22 kDa

histamine
Rabbit PC

none

CAMP

Rabbit PC

histamine

CAMP

cytosol

30 kDa

Rabbit PC

histamine

CAMP

membrane

27, 40 kDa

Rabbit GG

histamine +
forskolin

membrane

80, 120 kDa

Ca2+/PKC
carbachol

membrane,
cytosol

28, 36 kDa

Rabbit PC

PKC

?

2x 66 kDa

Rabbit PC

none

calmodulin

cytosol

100 kDa

Rabbit GG

none

Zn2+/Mn2+

cytosol

33 kDa

TABLE II: Protein kinase substrates found in gastric tissue and parietal cells.
For references, see text. Abbreviations: FGM - fundic gastric mucosa; GG
gastric glands; PC - parietal cells; PKC - protein kinase C.
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FIGURE 4: Structure of the cAMP-dependent protein kinase.
The kinase is a tetramer (RjCJ composed of two identical regulatory subunits (R)
and two identical catalytic subunits (C). Each regulatory subunit has two cAMP
binding sites.
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found to correspond to two cytosolic cAMP dependent protein kinases thought to
be Type I and Type II CAPK. When the glands were stimulated with histamine,
binding of the azido-cAMP ligand decreased 32 to 44%. This is consistent with the
hypothesis that when histamine increases endogenous cAMP, it binds to the
regulatory subunit of CAPK, leaving fewer binding sites available for the exogenous
ligand. Theoretically this should lead to increased CAPK activity in stimulated cells,
and in fact several investigators have demonstrated this67,68,69,70,71.

Histamine

stimulation increased the activity of CAPK in both rabbit and guinea pig fundic mucosa67,68,89.

The activation of CAPK was also found to reflect the tissue con¬

centration of cAMP70. A more detailed study of CAPK activity in isolated parietal
cells reported that the Type I isozyme was found predominately in the cytosolic
fraction while the Type II isozyme was found in both particulate and cytosolic frac¬
tions71. Histamine stimulation of these cells was shown to activate only the cytoso¬
lic Type I kinase71.

In contrast, forskolin was found to stimulate both forms of

CAPK71. These data suggest that Type I and Type II CAPK are compartmentalized
within the parietal cell and that histamine stimulation increases local concentra¬
tions of cAMP, thus selectively activating the Type I isozyme.
Other studies have attempted to identify putative substrates of CAPK in the
parietal cell727374,75. After preincubation with 32P-labe!ed orthophosphate, secretagogue is added to the tissue preparation. Phosphorylation changes are evalua¬
ted by homogenizing the cells, using differential centrifugation to separate soluble
and particulate material, and using one- and two-dimensional SDS-PAGE followed
by autoradiography. A number of phosphoproteins have been identified in this
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way, but it remains to see which of these actually play a role in acid secretion.
Using this methodology, Chew and Brown’2 have shown that stimulation with
histamine increases the phosphorylation of 27 and 40 kDa proteins in low speed
particulate fractions of parietal cells. Forskolin and cAMP analogues also increase
the phosphorylation of these proteins, suggesting that a cAMP-dependent
mechanism mediates the phosphorylation increase72.

Oddsdottir et aL73 have

reported that histamine, forskolin, and 8-bromo-cAMP stimulated the phosphory¬
lation of a 30 kDa cytosolic protein in rabbit parietal cells. Protein phosphorylation
began to increase within one minute of the addition of secretagogue and reached
a maximum at 15 minutes73. Malinowska et aL have found histamine-dependent
increases in protein phosphorylation in both soluble and particulate fractions74.
Phosphoproteins of 148, 130, 47, and 43 kDa were detected in the cytosolic frac¬
tion, while phosphoproteins of 130, 51, and 47 kDa appeared in the particulate
fraction.
Urushidani et aL have done extensive work characterizing a membranebound phosphoprotein in gastric glands. They examined subcellular fractions of
histamine-stimulated rabbit gastric glands and found 80 and 120 kDa proteins in
the heavy particulate fraction75.

This same fraction is also greatly enriched in

H+/K+-ATPase activity, as measured by K+-p-nitrophenyl phosphatase activity, in
histamine-stimulated gastric glands76.

Since FT/K+-ATPase activity can be used

as a marker for the apical membrane in stimulated cells, this has been referred to
as the apical-membrane rich fraction. The 80 kDa protein was also phosphorylated when glands were treated with DBcAMP, whereas neither carbachol-
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stimulation nor chelation of intracellular calcium affected its phosphorylation state77.
Like the H 7K+-ATPase, the 80 kDa protein is tightly membrane-associated77. The
80 kDa protein could also be phosphorylated in vitro by the addition of 32P-ATP to
the apical-membrane rich fraction. The addition of cAMP-dependent protein kinase
inhibitor blocked this reaction, suggesting that CAPK is at least partly responsible
for phosphorylating the 80 kDa protein77. Monoclonal antibodies against this 80
kDa protein have been used to show that within the gastric mucosa, it is found
only in parietal cells73. Immunocytochemistry further revealed that the 80 kDa pro¬
tein is localized to a fine, filamentous network within the parietal cell. This staining
pattern is similar to that of F-actin. When the cells are stimulated with histamine,
the distribution of the 80 kDa protein changes to a coarser, rugose pattern iden¬
tical to that seen for immunolocalization of the H+/K+-ATPase78. The change in the
staining pattern of the 80 kDa protein probably reflects the elaboration of the apical
membrane that is seen in the stimulated cell.
Far fewer substrates for protein phosphorylation have been identified in
carbachol-stimulated parietal cells. Carbachol-stimulation increased phosphoryla¬
tion of two 66 kDa proteins with different isoelectric points and a 36 kDa protein44.
Carbachol also induced a transient increase in the phosphorylation of a 28 kDa
protein44' The 36 and 28 kDa proteins are found in the 100,000 x g supernatant
and pellet, rather than the apical membrane fractions44. Several pieces of evidence
support the hypothesis that the carbachol-stimulated calcium signal mediates the
phosphorylation of these proteins. The calcium ionophore, ionomycin, was able
to stimulate phosphorylation of the 28 kDa protein, while 12-O-tetradecanoylphor-
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bol-13-acetate (TPA) was able to stimulate phosphorylation of the two 66 and the
36 kDa proteins.

TPA is a direct activator of the phospholipid-Ca2+-dependent

protein kinase also known as protein kinase C (PKC).

In addition, chelation of

intracellular calcium blocked phosphorylation of the 36 and 28 kDa proteins, as
well as the calcium signal and parietal cell secretory activity as measured by
aminopyrine uptake44.
in vitro phosphorylation of gastric mucosal membranes prepared from
homogenized rat fundic mucosa also suggests that Ca+ plays a role in gastric
protein phosphorylation79. Phosphorylation of an 88 kDa membrane protein was
dependent on Ca2+ but was not affected by cAMP, cyclic GMP (cGMP), or CAPK
inhibitor. This activity may represent a Ca2+-calmodulin-dependent kinase, since
trifluoperazine, an inactivator of calmodulin, blocked this Ca2+-dependent phospho¬
rylation.
Several other protein kinase activities have been described in gastric
mucosa. In rabbit gastric glands, a Zn2"-dependent kinase activity phosphorylates
a 33 kDa protein80.

However, because this kinase activity was observed in

homogenates made from a mixed population of cells, it may actually not be
specific to the parietal cell.

In homogenates made from parietal cells, several

protein kinase activities have been observed, including a Ca2+-phospholipiddependent kinase, two casein kinases that may correspond to casein kinase I and
II71, and a calmodulin-dependent kinase thought to be calmodulin kinase III81.
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CHAPTER TWO
THE TYPE II CAMP-DEPENDENT PROTEIN KINASE
As discussed in the previous section, earlier work on the parietal cell has
indicated that protein kinases may play a role in secretagogue-stimulated acid
secretion.

More specifically, the cAMP-dependent protein kinase (CAPK) is

thought to mediate histamine-stimulated acid secretion. The research presented
here focuses on the role of the regulatory subunit of the Type II CAPK (Rll). In
order to place this work in context, the literature on the Type II CAPK and Rll is
reviewed in this section.

PROTEIN KINASES-BACKGROUND AND HISTORY
Protein kinases catalyze the transfer of phosphate groups to substrate
proteins. Protein phosphorylation has been implicated in the regulation of many
cell processes, including synaptic transmission82, protein synthesis33, growth84,
secretion85, smooth muscle contraction and relaxation86, DNA synthesis87, and
glycogen metabolism88. Although almost a hundred different protein kinases have
been described, they are all thought to be related, with highly conserved catalytic
domains89. They can be divided into two broad categories: those that phosphorylate serine or threonine residues and those that phosphorylate tyrosine residues89.
Many of these enzymes are activated when an extracellular effector molecule binds
to a membrane receptor. This results in a change in the concentration of an intra¬
cellular second messenger that in turn activates the kinase.
phosphorylates one or more substrates.

The kinase then

As some of these substrates may
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themselves be protein kinases, the stimulus may lead to a cascade of phosphory¬
lation reactions that ultimately produce the physiological response characteristic
of the effector molecule.
Protein phosphorylation is an effective and sensitive regulator of cell function
because of its reversibility. The phosphate groups added by the kinases can be
removed by either phosphoprotein phosphatases or the reverse reactions of the
protein kinases themselves30. The mechanism is also made more responsive by
the fact that substrates are often phosphorylated by multiple kinases, and the
kinases themselves can act on more than one substrate. •
The fundamental model for protein kinase activity was provided by work
done on the regulation of glycogen metabolism88. The enzyme phosphorylase,
which catalyzes the initial step in glycogen breakdown, was found to exist in two
forms: an active, phosphorylated form and an inactive, dephosphorylated form.
Interconversion of the two forms was regulated by two enzymes: phosphorylase
kinase and phosphorylase phosphatase.

Like phosphorylase, phosphorylase

kinase was also found to exist in two forms, requiring the addition of a phosphate
group for activation. This implied that a second kinase existed. cAMP was also
known to play a role in epinephrine- and glucagon-stimulated glycogen break¬
down. The relationship of these facts was made clear when Walsh et al. isolated
the cAMP-dependent protein kinase (CAPK)91.
This work provided an elegant model for hormone-stimulated regulation
of a cellular process mediated by the activation and deactivation of protein kinases.
However it was also significant in that it first identified cyclic AMP-dependent kinase
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(Figure 5). This enzyme was soon found to be ubiquitous, phosphorylating a wide
variety of substrates in many organisms and tissues9293 in response to many
different stimuli. Nor was it confined to a single compartment of the cell. While
predominately identified in soluble fractions, it was also present in association with
particulate cellular matter, particularly in brain tissue94,95.

CYCLIC AMP-DEPENDENT PROTEIN KINASE (CAPK)
CAPK phosphorylates serine and threonine residues. The enzyme appears
to recognize these amino acids when a pair of basic amino acids is found in close
proximity on the amino terminal side96. Phys;. ogical substrates of CAPK include
other enzymes involved in carbohydrate metabolism as well as troponin I,
cholesterol esterase, tyrosine hydroxylase, and ATP-citrate lyase97. In addition the
enzyme exhibits broad substrate specificity in vitro that may not be physiological,
phosphorylating proteins such as histone, protamine, S-6 ribosomal protein, myelin
basic protein, and casein97. It has been hypothesized98 but not proven96 that all the
effects of cAMP are mediated by CAPK. At least one study appears to contradict
this hypothesis. In rat parotid, inhibition of the cAMP-dependent protein kinase in¬
hibited cAMP-dependent protein phosphorylation but did not interfere with cAMPevoked amylase release99.
In the absence of cAMP, CAPK is inactive.

The enzyme is a tetramer,

composed of two identical regulatory subunits (R) and two identical catalytic
subunits (C) that bind to each other with high affinity97. Each R subunit has two
cAMP binding sites. The two sites have differing affinities for cAMP100. However
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FIGURE 5: The cAMP-dependent protein kinase: mechanism of action.
Stimulatory and inhibitory external signals interact with receptors on the cell
surface. These interact in turn with the stimulatory and inhibitory GTP-binding
proteins, Gt and G,. G, stimulates the enzyme adenylate cyclase (AC) to convert
ATP to cAMP, whereas G, inhibits this reaction. AC can also be directly stimulated
by forskolin. The increase in intracellular cAMP activates the cAMP-dependent
protein kinase by binding to the regulatory subunit (R) and releasing free catalytic
subunit (C). C catalyzes the addition of a phosphate group (P) to a substrate
protein (X). The activated protein (X-P) causes a cellular response.
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cAMP binding to the R subunit is cooperative94.

When cAMP binds to the R

subunit, its affinity for the C subunit is diminished by a factor of 104, and it releases
the free catalytic subunit97. The formula for this reaction is:
R2C2 + 4 cAMPr=i R2(cAMP)4 + 2C 97
The free catalytic subunit is then active in the presence of ATP and Mg2+. This
activity can be inhibited by adding either a heat-stable inhibitor protein that has
been purified from rabbit skeletal muscle101 or a synthetic substrate analogue,
known as CAPK pseudosubstrate102.
Although the literature commonly refers to CAPK as though it were a single
enzyme, there are in fact two isozymes103, referred to as Type I and Type II CAPK.
These were first noted to elute differently from DEAE-cellulose103.

The two

isozymes were found to have different affinities for ATP, cAMP, and the catalytic
subunit104. While the concentration of CAPK present in a mammalian tissues is
generally constant105, the relative proportions of the two isozymes vary from tissue
to tissue93 and between species in the same tissue 06.

Subsequently it was dis¬

covered that the isozymes differed in the regulatory subunit; the catalytic subunit
in each was found to be the same.
Rl and Rll differ in both their chemical and biological properties.

While

review of the literature reveals a range of sizes for each subunit, Rl is generally
smaller than Rll.

Rl has been reported to have a molecular weight between 47

and 49 kDa, while Rll ranges from 51 to 62 kDa. They have different patterns of
immunoreactivity; antiserum raised against the Type II kinase does not react with
the Type I isozyme107.

Similarly, peptide mapping of Rl and Rll gave further
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evidence to support the suggestion that the two forms had different amino acid
sequences108. Amino acid analysis confirmed this suspicion’09.

Final proof was

provided when the two proteins were sequenced in 1984110,111. Rll also differs from
Rl in its ability to undergo "autophosphorylation" by the catalytic subunit112. This
reaction will be more fully discussed in the next section.
The occurrence in nature of two kinds of regulatory subunit, often found
within the same cell, suggests that they serve different purposes.

Numerous

studies done in many different systems support this hypothesis.

Differential

activation of the two protein kinase isozymes has been seen in rabbit corpora lutea
stimulated with human chorionic gonadotropin113, mouse pituitary tumor cells
stimulated with corticotropin releasing factor114, rat liver stimulated with glucagon115,
and histamine-stimulated rabbit parietal cells71. In one study, different patterns of
kinase activation were seen in the same cell line when two different hormones were
used to stimulate cells116.

In cells grown from rat calvaria, parathyroid hormone

stimulated Types I and II equally, whereas PGE2 stimulated Type II CAPK almost
exclusively.

Site-specific cAMP analogues have also been used to determine

whether cAMP binding to one of the two cAMP binding sites preferentially activates
one form of the enzyme.

In a human colon cancer line, the site-specific cAMP

analogue 8-chloro-cAMP decreased the amount of Rl and increased the amount
of two species of Rll117. Lastly, changes in the relative amounts of Rl and Rll have
been seen in Friend erythroleukemic cells undergoing differentiation118.
This differential activation may reflect subcellular compartmentalization of the
isozymes. Data from several systems, including the rabbit parietal cell, support this
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hypothesis. In rabbit parietal cells the Type II kinase is found in both soluble and
particulate fractions, whereas the Type I is found only in soluble fractions71. Simi¬
larly, in the rat parotid Rll is the dominant form in the particulate fraction, while Rl
is concentrated in the soluble fraction119.
The distribution of CAPK activity has also been studied in forskolinstimulated cells 71,114.

Forskolin activates adenylate cyclase, which catalyzes the

formation of cAMP. When forskolin was used, both forms of CAPK were activated
equally.

These data suggest that specific hormone-receptor interactions may

activate only a portion of the adenylate cyclase in the cell, increasing the local con¬
centration of cAMP, and thus activating only that form of CAPK that is found in
close proximity. However an alternative possibility is that hormones may initiate
different modifications to the two proteins, enabling them to respond differently to
an increase in second messengers.
Other important differences exist between the two kinds of regulatory
subunit. However the data presented in this paper focus primarily on the role of
Rll in histamine-stimulated acid secretion in the isolated rabbit parietal cell. The
properties of the Type II regulatory subunit are therefore reviewed more completely
in the next section.

THE TYPE II REGULATORY SUBUNIT OF CAMP-DEPENDENT PROTEIN
KINASE
The regulatory subunit of the Type II CAPK (Rll) can be divided into several
distinct domains.

It is, like Rl, a cAMP-binding protein with two cAMP binding
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sites100.

It also has at least five potential phosphorylation sites per molecule’20.

However, when isolated from bovine cardiac muscle, Rll in fact contains between
1.2 and 2.7 mol phosphate/mol Rll monomer121. Rll also possesses a domain that
acts to inhibit the kinase activity of the catalytic subunit and a region that interacts
with another Rll monomer to form a dimer97 (Figure 6).

Autophosphorvlation of Rll
The tendency of Rll to undergo "autophosphorylation" by the catalytic
subunit of CAPK is one of its most distinctive features112'122. In the presence of Mg2+
and ATP, Rll is phosphorylated at a single serine residue, incorporating 1 mole of
phosphate per mole of Rll subunit.

This reaction demonstrates a broad pH

optimum (pH 6 to 8.5) and a Kh for ATP of 0.4 juM123.

In contrast, the K% for

exogenous proteins is about 12 ^M123. Because of this high affinity, it has been
assumed that in vivo this site is usually phosphorylated.

Indeed, when live rats

were injected with 32P„ the majority of the Rll prepared from brain, heart, and liver
cytosol was found to be phosphorylated124.

Unlike the action of the catalytic

subunit on exogenous proteins, the phosphorylation of Rll can take place in the
undisassociated holoenzyme. This reaction is therefore unaffected by cAMP, pro¬
tein kinase inhibitor (which acts on free C), or holoenzyme concentration125. The
autophosphorylation reaction is thought to regulate the activity of Type II CAPK,
since phosphorylation affects the rate of reassociation between C and Rll126. The
dephosphorylated form reassociates with C at a rate that is at least five times
greater than that of phosphorylated Rll (Rll-P).

Thus phosphorylation of Rll

GSK3

THERTOLYSIN
CKII

CAPK(AUTO)

FIGURE 6: The regulatory subunit of Type II cAMP-dependent protein kinase.
This diagram of the Rll dimer shows regions susceptible to proteolytic digestion,
potential phosphorylation sites, the two cAMP binding sites, and the dimerization
domain. Arrows mark regions susceptible to different proteases. STAPH V8 staphylococcus aureus V8 protease; SER - serine residue; GSK 3 - glycogen
synthase kinase 3 phosphorylation sites; CK II - casein kinase II phosphorylation
sites; CAPK(AUTO) - autophosphorylation site of cAMP-dependent protein kinase;
P - phosphate.
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prolongs the activity of the kinase.
There are two mechanisms by which the phosphate group can be removed
from the autophosphorylated Rll123,124. First, the phosphorylation reaction can be
reversed in the presence of ADP and Mg2+123.

Unlike the forward reaction, this

reaction demonstrates a pH optimum at pH 5.5. The phosphate group can also
be removed by phosphatases, including a phosphatase found in bovine cardiac
muscle127.

Other phosphorylation sites on Rll
The autophosphorylation reaction is not the only phosphorylation reaction
associated with Rll.

jn vitro, glycogen synthase kinase 3 (GSK 3) and casein

kinase II (CK II) can phosphorylate other serine residues, distinct from the serine95 which is autophosphorylated128129. GSK 3 phosphorylates serine-44 and serine47, while CK II phosphorylates serines-74 and 76. The CK II and autophosphoryl¬
ation sites can be distinguished with phosphopeptide mapping130.

It must be

recognized that these in vitro phosphorylation activities may not be physiological.
Instead these reaction may simply reflect a similarity in the amino acid sequence
of the phosphorylation sites of glycogen synthase and Rll, since C also phosphory¬
lates glycogen synthase. However, Rll isolated from rat soleus that had been incu¬
bated with “Pi is phosphorylated at the CK II site, indicating that this site is a
substrate in vivo129. Phosphorylation at the CK II site has no known effect on the
function of Rll131. However a phosphorylated form of Rll has been found to have
topoisomerase activity132, although the phosphorylation site responsible for this
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activity has not been identified.
The phosphorylation state of Rll has been studied in several systems. In
smooth muscle from rat trachea, incubation with isoproterenol, a /3-adrenergic
agonist that increases the cAMP concentration, caused the amount of phosphorylated Rll to decrease133. The direct addition of cAMP to muscle extracts in vitro
also caused a decrease in phosphorylated Rll’33. A similar dephosphorylation of
a 55 kDa Rll was seen when cAMP was added to membranes prepared from rat
liver134.

While the phosphorylation site in rat tracheal tissue was not identified,

phosphopeptide maps of the 55 kDa phosphoprotein described in rat liver
membranes were identical with those of Rll phosphorylated by CK II. cAMP also
caused the dephosphorylation of the autophosphorylated CAPK regulatory subunit
in Blastocladiella emersonii zoospores135. Although zoospores have only one type
of R, it appears to resemble Rll135. These cAMP-dependent reactions indicate that
endogenous phosphatases are capable of dephosphorylating Rll.

The cAMP-

dependence of these reactions may indicate that the holoenzyme must disas¬
sociate for the phosphate group to be accessible.

Alternatively one or more

phosphatases may be directly or indirectly activated by the presence of cAMP.

Rll subtypes
Rll is further distinguished from Rl by the existence of a number of different
subclasses. As many as six have been identified136, and in at least one instance
two different forms have been found within the same cell137. Like Rl and Rll, the
Rll subtypes may be under differential control137. The two forms that have been
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most extensively studied are referred to as the brain and heart isoforms, Rll-B and
Rll-H. They were initially distinguished from one another in these tissues by their
differences in immunoreactivity138,139. It was also observed that autophosphoryla¬
tion changes the mobility of Rll-H on SDS-PAGE, whereas that of Rll-B remains
unchanged140. While the heart subclass is found in most tissues, the neural form
seems to be more restricted in its distribution.

It has been found in ovarian

tissue141, testis, and adrenal tissue142 as well as brain. The two forms also seem to
differ in their intracellular distribution. Rll-H is predominately cytoplasmic while RllB associates with particulate material138. Inspection of the sequences of neural and
non-neural subtypes has shown that each possesses sites for autophosphorylation
and phosphorylation by CK II142. However the neural type does not appear to have
the consensus sequence corresponding to the glycogen synthase kinase 3 phos¬
phorylation site142.

Interactions with other proteins
Studies undertaken in brain first suggested that Rll might play a role other
than regulation of CAPK.

Previously it was believed that in eukaryotic cells, all

effects of cAMP were mediated by CAPK98. Thus it was assumed that the cAMPbinding proteins Rl and Rll served no other purpose than to inhibit the catalytic
subunit. However in brain, Rll is found to be tightly associated with microtubuleassociated protein 2 (MAP 2)143.

Neither cAMP nor catalytic subunit inhibit this

binding, suggesting that it involves a domain that does not interact with cAMP or
C.

In brain, Rll also interacts with a 75 kDa calmodulin-binding protein144, the
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calmodulin-dependent phosphatase calcineurin169, and an unidentified 80 kDa
protein145. Rll-binding proteins are also found in heart but appear to be different
from those found in brain145.
These Rll binding proteins may serve to fix and compartmentalize CAPK,
bringing it in close proximity with specific substrates. Alternatively, the interaction
of Rll with proteins other than C may indicate that Rll serves functions other than
the regulation of the kinase.

The latter hypothesis is consistent with evidence

suggesting that in some cells free Rll exists in excess of C'18. In either case it is
plausible that Rll may be involved in cytoskeletal regulation.

Not only does Rll

associate with MAP-2, a protein found in close proximity to microtubules; immunocytochemistry localized Rll to microtubules, microtubule-organizing centers, and
parts of the Golgi complex146. This association with the cytoskeleton is of particular
relevance in the evaluation of the role of Rll in the parietal cell, since the
cytoskeleton is thought to be critically involved in the morphological transforma¬
tion associated with secretion.
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CHAPTER 3
MATERIALS AND METHODS
MATERIALS
New Zealand white rabbits (2-3 kg) were obtained from Camm (Wayne, NJ).
Pronase (Protease E), collagenase (type I), histamine chloride, CAPK catalytic
subunit, kemptide, heat stable CAPK inhibitor from rabbit muscle (Product No. P
5015), and CAPK pseudosubstrate (Product No. P3294) were purchased from
Sigma Chemical Co. (St. Louis, MO). Forskolin was purchased from Calbiochem
(La Jolla, CA). Cimetidine was obtained from SmithKIine and French (Philadelphia,
PA).

[14C]aminopyrine was obtained from Amersham (Arlington Heights, IL).

[gamma 32P]-ATP (5-10 Ci/mmol) was purchased from New England Nuclear
(Boston, MA). [125l]-goat anti-mouse IgG and 8-azido-[32P]-cAMP were purchased
from ICN (Costa Mesa, CA). Calmodulin was produced from bovine brain by Dr.
James Goldenring (Yale University, New Haven, CT) using the method of
DeLorenzo and Goldenring147. Molecular weight markers, carbamylated isoelec¬
tric focusing standards, and Protein A beads were products of Pharmacia (Piscataway, NJ). Immobilon P was purchased from Millipore (Bedford, MA). Cyclic
AMP assay kits were bought from Diagnostic Products Corporation (Torrance, CA).
Okadaic acid was a gift from Dr. Harold Rasmussen (Yale University, New Haven,
CT). A monoclonal antibody against the gastric H'/K-ATPase was the gift of Dr.
Adam Smolka (University of South Carolina, Charleston, SC).

The monoclonal

antibodies 6H11, 2E11, and 4A5 against the 80 kDa parietal cell apical membrane
protein were the gift of Dr. John Forte (University of California, Berkeley, CA).
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Polyclonal antibodies against rat heart and rat brain Rll were the gift of Dr.
Suzanne Lohmann and Dr. Ulrich Walter (University of Wurzburg, West Germany)
and Dr. Pietro DeCamilli (Yale University, New Haven, CT). All other reagents were
from standard suppliers and were of the highest purity available.

PREPARATION OF CELLS
Parietal cells were prepared by a modification of techniques described for
isolation of gastric glands25 and parietal cells42148 149.

After high pressure aorto-

celiac perfusion, fundic mucosa was bluntly separated from submucosa. Mucosal
fragments were digested for 20 min at 37 °C under 100% 02 with 0.5 mg/ml
pronase in 50 ml of solution 1 (130 mM NaCI; 12 mM NaHC03; 3 mM NaH2P04;
3 mM Na2HP04; 3 mM I^HPO,; 2 mM MgS04; 1 mM CaCI2; 0.03 mM bovine serum
albumin (fraction V) (BSA); 11 mM dextrose; and phenol red, 10mg/l, pH 7.4).
After collagenase digestion the tissue was washed three times by pelleting and
resuspension in solution 2 (132.4 mM NaCI; 5.4 mM KCI; 5 mM Na2HP04; 1 mM
NaH2P04; 1.2 mM MgS04; 1 mM CaCI2; 0.5 mM dithiothreitol (DTT); 1 mM pyru¬
vate; 10 mM HEPES (N-2-hydroxyethylpiperazine-N’-2-ethanesulfonicacid) pH 7.4;
0.06 mM BSA; 10 mM dextrose; and phenol red 10mg/l). After washing, the tissue
was resuspended in 50 ml of solution 1 containing collagenase 0.8 mg/ml and
allowed to incubate for 45 min at 37 °C under 100% 02. DNAse 0.5 mg/ml was
added for the last ten minutes. Dispersed cells were then washed three times in
solution 2, filtered through 30 mm nylon mesh and resuspended in 10 ml of solution
2.
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The cells were then fractionated on discontinuous Nycodenz gradients.
These were prepared in the following manner: isotonic sterile Nycodenz solution
containing 0.06 mM BSA was diluted 1:1 (density 1.075 g/ml) and 1:2 (density
1.050 g/ml) with diluent solution (5 mM Tris-HCI, pH 7.4; 3 mM KCI; 0.3 mM CaNaEDTA; 128.3 mM NaCI; and 0.06 mM BSA). Gradients were prepared by placing
5 ml of the 1:1 solution below 8 ml of the 1:2 solution. Two ml of the cell suspen¬
sion were layered on top of each gradient, which was then centrifuged at 200 x g
for 10 min at 10 °C. Enriched parietal cells (purity 85 ± 5%) were removed from
the interface between the 1.075 g/ml and the 1.050 g/ml solutions. These cells
were washed three times by pelleting and resuspension in solution 2. Solution 2
was then used to bring the cells to the desired concentration. All steps used a
Beckman J6M refrigerated centrifuge.

PREPARATION OF SUBCELLULAR FRACTIONS
Purified parietal cells were resuspended in solution 2 to a concentration of
5 x 10s cells/ml. After a 10 min recovery period at 37 °C under 100% 02, cells
were incubated for 45 min more with either 100 mM cimetidine (unstimulated cells)
or 100 juM histamine plus 10 ^M forskolin (maximally stimulated cells). Subcellular
fractions were then prepared using a modification of the method developed for
gastric glands by Urushidani et aL75.
Cells were pelleted at 50 x g for 5 min at 4 ° C. Homogenization buffer (110
mM mannitol; 10 mM sucrose; 150 mM NaCI; 1 mM MgCI2; 5 mM benzamidine;
1 mM PMSF; 1 /uM aprotonin; and 1 ^M leupeptin) was added to the cell pellets
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(0.5 ml/million cells), which were then homogenized on ice with 15 strokes of a
Potter-Evelyn homogenizer at 900 rpm.

Subcellular fractions were then prepared

by differential centrifugation (Figure 7). Cell homogenates were first centrifuged
for 5 min at 40 x g to make the P0 pellet. The supernatant from this pellet was then
centrifuged for 10 min at 4000 x g to make the P, pellet. The supernatatant was
again centrifuged, this time for 10 min at 14,500 x g to make the P2 pellet. Finally,
the remaining supernatant was spun once more at 48,500 x g for 60 min to
produce the P3 pellet and the final, high-speed S3 supernatant. All centrifugation
was conducted at 4°C. Pellets were washed with homogenization buffer and
resuspended in resuspension buffer (200 mM sucrose, 100 mM NaCI, and 0.5 mM
EDTA). Low speed centrifugation was undertaken in a Beckman J6M refrigerated
centrifuge, while the final high-speed spin required a Sorvall OTD-2 ultracentrifuge.

CHARACTERIZATION OF SUBFRACTIONS
Immunoblotting
Western blotting was used to determine the distribution of the H7K+-ATPase
and the 80 kDa apical membrane protein77.

Samples of both stimulated and

unstimulated subcellular fractions were resolved on 10% SDS-PAGE minigels and
transferred to Immobilon overnight at 50 milliamps150.

Blots were blocked with

Blotto (5% non-fat dry milk; 0.1% Triton X-100; 25 mM Tris HCI, pH 7.5; and 150
mM NaCI) for two hours. The blots were then incubated overnight with either a
monoclonal antibody directed against the H'/IC-ATPase (1:150 dilution) or a
mixture of three monoclonal antibodies against the 80 kDa protein (1:100 dilution).
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->S3

FIGURE 7: Protocol for preparation of subcellular fractions.
Differential centrifugation was used to prepare subcellular fractions from homoge
nized parietal cells. For a more detailed description, see text. (P - pellet; S - super
natant).
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After this incubation, blots were washed 3 times in Blotto, then incubated with [125l]goat anti-mouse IgG for 2 hours. The blots were then washed 3 more times with
Blotto before drying.
Dried blots were exposed to x-ray film to locate the bands of interest. The
data were quantified by cutting out the labeled bands and counting them in a
gamma counter. Data were then expressed as cpm/mg total protein in the original
sample.

Cyclic AMP-dependent protein kinase activity
CAPK activity was determined using kemptide102, a synthetic substrate
peptide for CAPK. Prior to assay, membrane fractions were solubilized in 0.5%
Triton X-100 for 30 min on ice. In the final reaction mixture, the Triton was diluted
to 0.04%.

Cytosolic fractions were used without any further preparation.

standard 50 /xl reaction mixture contained 5

The

kemptide; 25-50 jug protein sample;

50 mM HEPES, pH 7.0; 10 mM MgCI2; and 100 /uM [gamma-32P]-ATP (100-400
cpm/pmol). Reactions were also performed in the absence of kemptide. Another
set of reactions was performed in the presence of 10 mM cAMP. All reactions were
allowed to proceed at 35 °C for 30 min. After 30 min, four 10 n\ samples were
withdrawn from each reaction tube and spotted on 2 x 1 cm pieces of Whatman
P81 paper. This is a basic paper that binds the positively charged kemptide. Free
ATP was then removed by washing the pieces of paper 4 times for 10 min each
in 50 mM phosphoric acid. After an acetone rinse, papers were then dried and
Cherenkov radiation counted. The phosphorylation of kemptide was determined
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by subtracting the amount of bound radioactivity seen in the presence of sample
alone from that seen in the presence of kemptide.

Other parameters
To quantify the presence of nuclear material in subcellular fractions, DNA
content was determined using the method of West et aL151. Fractions were also
evaluated for the presence of mitochondria using cytochrome C oxidase activity
as a marker. Cytochrome C oxidase activity was determined by the method of
Peters et aL152. Protein content of each fraction was determined by the method of
Bradford153, using BSA as a standard.

IN VITRO PHOSPHORYLATION
]n vitro phosphorylation of endogenous proteins in subcellular fractions was
assayed using 10 /xl of protein sample in a reaction volume of 100 /xl.

The

standard reaction mixture contained 50 mM HEPES (pH 7.0), 10 mM MgCI2, 0.5
mg/ml DTT, and 10 /xM [gamma-32P]-ATP. Reactions were carried out in both
the presence and absence of 10 /xM cAMP.

Reactions were initiated by the

addition of [gamma-32P]-ATP and were allowed to proceed for 60 sec at 35 °C.
Reactions were stopped by the addition of 50 /xl of 3% SDS stop solution followed
by boiling for 5 min. After the samples cooled, 20 /xl of 2-mercaptoethanol was
added to each sample prior to loading for SDS-PAGE.
The standard reaction mixture was varied by changing the concentration of
Mg2+ (0.1 mM to 30 mM), ATP (0.1 /xM to 50 /iM), and cAMP (0.1 nM to 10 /xM).
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A time course of the standard reaction was performed by stopping the reactions
at times from 5 sec to 5 min. To determine whether the kinase could also use
GTP as a substrate, in some experiments GTP (0.1 mM to 50 mM) was substituted
for ATP. To determine whether cAMP had a unique effect on the phosphorylation
reaction, cyclic GMP (0.01 /zM to 10 mM) was substituted for cAMP in some
experiments. The pH of the reaction was varied by using MES and HEPES buffers
ranging from pH 5.5 to pH 8.0. Reactions were also carried out in the presence
of the heat stable CAPK inhibitor (1 Mg/ml), CAPK pseudosubstrate (0.2 units/jul),
CAPK catalytic subunit (0.1 units//zl), calmodulin (0.01 mg/ml), CaCI2 (1 mM),
MnCI2 (10 mM), ZnS04 (10 mM), or EDTA (2 mM; exogenous MgCI2 was not
added to the reaction containing EDTA).
To evaluate the presence of a phosphatase in the P,, standard in vitro
phosphorylation reactions were stopped after 60 sec with 10 mM EDTA. cAMP
was immediately added and the reaction was then stopped at various time points
from 0 sec to 4 min with 50 /zi of 3% SDS stop buffer. The dephosphorylation
seen in the presence of 10 /zM cAMP was evaluated by observing the effect of
known phosphatase inhibitors including MnCI2 (10 mM), ZnS04 (10 mM), NaF (50
mM), pyrophosphate (10 mM), and okadaic acid (0.01 /iM to 10 mM). At the end
of standard 1 min phosphorylation reactions, 10 mM EDTA was added to stop
further phosphorylation. Potential phosphatase inhibitors were then added to the
reaction mixture with 10 /zM cAMP. Reactions were allowed to run for 3 min more
before being stopped with 1% SDS.
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PHQSPHOAMINO ACID ANALYSIS
Phosphoamino acid analysis was performed on phosphoproteins separated
on either one- or two-dimensional gels using a previously described modification
of the method of Hunter and Sefton154,155.

This method allows separation of all

three stable phosphoamino acid species: phosphoserine, phosphothreonine, and
phosphotyrosine.

8-AZIDO-cAMP BINDING STUDIES
Subcellular fractions were assayed for cAMP-binding proteins using 8-azido[32P]-cAMP, a photoaffinity probe which binds competitively at cAMP-binding sites.
Upon excitation with ultraviolet light, this compound generates a free radical that
inserts into a carbonyl bond, thus binding it irreversibly to the substrate protein.
Reaction mixtures (90 nI) containing 50 mM HEPES, pH 7.0; 0.1 mM IBMX;
10 mM MgCI2; and 50-100 ^g of the protein sample were prepared in a microtiter
plate and placed on ice. In semi-darkness 10 n\ of 8-azido-[32P]-cAMP was added
to each reaction. Control reactions contained in addition 100 juM nonradioactive
cAMP, After mixing, the microtiter plate was wrapped in foil, placed on ice, and
incubated on a rocker platform for 30 min. The plate was then unwrapped and
exposed to a high power UV light (XXI5, Ultra-Violet Products Inc.) at 6 inches for
5 min. Reactions were then stopped by the addition of 3% SDS stop solution (1%
SDS final concentration) or isoelectric focusing stop solution (see Methods: Twodimensional gel electrophoresis).

This allowed samples to be resolved by one-

or two- dimensional gel electrophoresis.
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IMMUNQPRECIPITAT1QN
Standard 100 jul phosphorylated reaction mixtures were used. After being
stopped by the addition of SDS to a final concentration of 1% and boiling, samples
were diluted 1:9 with RIPA156 buffer (150 mM NaCI, 10 mM Tris HCI, pH 7.4, 10
mM sodium pyrophosphate, 20 mM NaF, 1 mM EDTA, 1% sodium deoxycholate,
and 1% Triton X-100) with 0.5 mg/ml BSA and 5 mM benzamidine.

Polyclonal

antisera against rat heart Rll and rat brain Rll were used to immunoprecipitate
these samples. Five jul of undiluted antiserum, 5 jul of non-immune rabbit serum,
or 5 /xl of RIPA were then added to each sample.

Reaction mixtures were then

incubated overnight at 4°C with constant agitation.

Immune complexes were

immunoprecipitated by incubation for 2 hours with 3 to 5 mg of pre-swollen Protein
A-sepharose beads. The beads were pelleted for 5 min at 1000 x g, then washed
three times in RIPA with 0.5 mg/ml BSA and 0.1% SDS, followed by two washes
with RIPA alone. The washed beads were boiled for 5 min in 100

fi\

of 1% SDS

stop solution to remove the adherent proteins. The beads were then pelleted and
the supernatants collected for SDS-PAGE resolution.

WHOLE CELL STUDIES
Measurement of acid secretion
Acid secretion was assessed by the semi-quantitative uptake of [14C]aminopyrine (AP) using a modification of the method of Berglindh157 28.

A parietal cell

suspension containing 1.5x106cells/ml in solution 2 was pre-incubated with 2.12
nmol/ml [14C]AP (specific activity 4.366 Bq/nmol) for 30 min at 37 °C under 100%
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02. Following pre-incubation, 100 I aliquots (150,000) cells were added to 96 well
n

microtiter plates with integral durapore (Millititer SV) membrane filters (5.0

pore

size).
Cells were then incubated with okadaic acid (concentration 0.01 mM to 3
jizM), the CAPK inhibitor H-8 (concentration 0.01 mM to 30 juM), or control (an equal
volume of solution 2). Each condition was performed in triplicate. The plates were
then placed in an oxygenation chamber and oxygenated at 370 C for 30 minutes’53.
At the end of this time period histamine (10 *xM) was added.

In some okadaic

acid experiments, a combination of histamine (100 juM) and forskolin (10 mM) was
used instead. Cells were then incubated for an additional 45 min in the presence
of 100% 02 at 37 °C. At the end of this incubation period cells were rapidly sepa¬
rated from incubation media by vacuum filtration. The membrane filters containing
the cells were dried, punched into scintillation vir's, and counted in a liquid scintilla¬
tion counter. Non-specific binding of [,4C]AP to membrane filters was measured
in wells containing an equal amount of isotope but no cells.

This non-specific

binding was subtracted from binding measured in the presence of cells. Data were
then expressed as a percentage of maximal [14C]AP uptake.

Measurement of cAMP concentration
Cyclic AMP was assayed using a commercial assay kit (Diagnostic Products
Corp.). Parietal cells were incubated in the same manner used for the secretion
assay.

Each condition was performed in duplicate.

After vacuum filtration, the

membrane filters containing the cells were punched into tubes containing 0.5 ml
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ice-cold 3% perchloric acid, vortexed for 20 sec, and stored at -70 °C until assay.
Immediately prior to assay samples were thawed and stored on ice before adding
100

ii\

of cold 30% KHC03, bringing the pH to 6.0. The samples were centrifuged

and 100

ill

of supernatant was assayed for cAMP by competitive protein binding

assay158. Results were expressed as pmol/106 cells.

GEL ELECTROPHORESIS
One-dimensional SDS-PAGE
Proteins were resolved using a modification of the method of Laemmli159.
Discontinuous sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDSPAGE) was performed using 10% separating gels with 4% stacking gels cast on
Gelbond PAG film. After electrophoresis, the gels were stained with Coomassie
blue, dried in a forced air oven at 60 °C, and exposed to x-ray film (Kodak XAR5) at -700 C for 8 to 120 hours. Molecular weights were determined using standard
protein molecular weight markers.
Two methods were used to quantify protein phosphorylation.

In some

cases, a Biorad densitometer was used to measure the optical density of
phosphorylated bands detected by autoradiography. Alternatively, 32P incorpora¬
tion was determined by excising bands from dry gels.

The radioactivity of the

band was then measured using a liquid scintillation counter. In each method, data
were expressed as a percentage of maximal phosphorylation.
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Two-dimensional gel electrophoresis
Proteins were separated on two-dimensional isofocusing/SDS-PAGE using
a modification of the method of O’Farrelf60. Samples were prepared by adding an
equal volume of isoelectric stop buffer (4% Triton X-100; 4% 3-10 ampholines; 10%
2-mercaptoethanol; 9.5 M urea).

Isoelectric focusing in the first dimension was

accomplished in polyacrylamide tube gels using 3 to 10 ampholines (4%). In the
second dimension, proteins were separated by SDS-PAGE, as described above.
After electrophoresis, the gels were handled in the manner described for one¬
dimensional gels.

Isoelectric points were determined using carbamylated

standards.

STATISTICAL METHODS
Measurements of [14C]aminopyrine accumulation and cAMP levels were
compared to controls using a t-test for paired samples.
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CHAPTER 4
RESULTS
Previous studies using isolated rabbit parietal cells have shown that
histamine stimulates the accumulation of [14C]aminopyrine, a marker for parietal cell
acid secretion157 (Figure 8). Histamine stimulation also results in an increase in the
intracellular concentration of the second messenger cAMP157 (Figure 8). The only
known function of cAMP is activation of the cAMP-dependent protein kinase58,
which phosphorylates a wide variety of substrate proteins97. Several groups have
identified a number of histamine-stimulated phosphoproteins in rabbit parietal cells
and gastric glands72 73 74 75.

We hypothesized that histamine stimulation might

change the phosphorylation state of proteins found in actively secreting parietal
cells. If such proteins were found, they would be likely intermediaries in histaminestimulated acid secretion. By preparing subcellular fractions from homogenized
cells we hoped to be able to localize phosphorylation changes to specific intracel¬
lular compartments.
Subcellular fractions prepared from resting and stimulated parietal cells were
therefore characterized.

These fractions were then assayed for kinase activity.

This survey revealed that the apical membrane-rich fraction in stimulated parietal
cells possesses both kinase and phosphatase activities that act on a 52 kDa
protein substrate. The protein was identified as the regulatory subunit of Type II
CAPK (Rll). Whole cell secretion studies were then undertaken using a phospha¬
tase inhibitor and an inhibitor of CAPK, to determine whether the kinase or a
phosphatase played the key role in parietal cell acid secretion.

57

FIGURE 8: Effect of histamine stimulation of isolated rabbit parietal cells on
fuC1aminopyrine uptake and cellular cAMP content.
Isolated rabbit parietal cells were incubated with histamine (10 /xM).
[,4C]
aminopyrine accumulation and cellular cAMP content were measured as described
in Chapter 3. Top panel: time course of [,4C]aminopyrine uptake. Bottom panel:
time course of cellular cAMP content.
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CHARACTERIZATION OF SUBFRACTIONS
When Urushidani and Forte characterized subtractions prepared from rabbit
gastric glands, they used IC-p-nitrophenyl phosphatase as a marker for H+/K+ATPase activity7'. They reported that in resting glands, the bulk of the activity was
present in the microsomal P3 fraction. However in histamine-stimulated glands, the
activity in P3 decreased by 50%. This decrease was accompanied by a striking in¬
crease in activity in the apical membrane-rich P, fraction 75. This data supported
the hypothesis that in the stimulated cell, the H YK+-ATPase moves from the lighter
tubulovesicles to the heavier apical membrane. The same group has also des¬
cribed an 80 kDa actin-binding protein that additionally serves as a marker for the
apical membrane77.

Histamine stimulation changed the phosphorylation state of

this protein without altering its subcellular distribution.
In our preparation, made from isolated rabbit parietal cells rather than
glands, we used a monoclonal antibody against the H+/K+-ATPase to localize the
proton pump and characterize the subcellular fractions.

In agreement with pre¬

vious studies, we found that in histamine-stimulated cells the H */K+-ATPase moved
from the microsomal P3 fraction to the heavier P0 and P, (Figure 9).

These

fractions, but particularly P,, in both resting and stimulated cells, also showed
enriched immunoreactivity with a monoclonal antibody against the 80 kDa actinbinding protein described above (Table III). The presence of these markers in the
P, subcellular fraction is consistent with the conclusion that the P, fraction was
enriched with apical membrane. The P0 fraction exhibited somewhat similar cha¬
racteristics, but had the highest DNA content (Table III), indicating the additional
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FIGURE 9: Distribution of the HVKf-ATPase in subcellular fractions prepared from
parietal cell homogenates.
Western blot analysis was used to study the distribution of the H+/K+-ATPase in
subcellular fractions from maximally stimulated and unstimulated parietal cells.
SDS-PAGE was used to resolve proteins from all subcellular fractions from both
unstimulated (V) and maximally stimulated (S) cells (15
of protein per sample).
Western blot analysis was then performed as described in Chapter 3, using a
monoclonal antibody against the H "/IC-ATPase. PO, PI, P2, P3 - membrane frac¬
tions; S3 - cytosolic fraction; V - unstimulated; S - maximally stimulated; H/K H+/K"-ATPase.
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TABLE III: Characterization of subcellular fractions.
All fractions in both stimulated and unstimulated cells were assayed for DNA
content, cytochrome C oxidase activity, 80 kDa protein immunoreactivity, and
cAMP-dependent protein kinase activity. Unstimulated cells were treated with
cimetidine (100 /iM). Stimulated cells were treated with histamine (100 ^M) and
forskolin (10 mM). For materials and methods see Chapter 3. V - unstimulated; S stimulated; P0, P„ P2, and P3 - membrane fractions; S3 - cytosolic fraction.
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presence of nuclear material.

The P, fraction was slightly enriched in DNA.

Cytochrome C oxidase activity, a mitochondrial marker, was enriched in the P0 and
P, fractions (Table III). From these data it was concluded that the P, fraction is the
apical membrane-rich fraction, although it also contains some nuclear and
mitochondrial contaminants.

IN VITRO PROTEIN PHOSPHORYLATION IN SUBCELLULAR FRACTIONS
Endogenous phosphorylation was assayed in all subcellular fractions
prepared from both resting and stimulated parietal cells (Figure 10) in the presence
and absence of cAMP. In the presence of 10 mM Mg2+ and 10 mM ATP, many
proteins were phosphorylated in all fractions. However the most prominent and
consistent findings were observed in the P, apical membrane fraction and the S3
cytosolic fraction (Figure 11).
In the stimulated P, a protein with the molecular weight of 52 kDa (pp52)
was phosphorylated in the absence of cAMP. The time course of this activity was
extremely rapid, reaching maximal phosphorylation within 45 sec at 35°C (Figure
12). The phosphorylation of pp52 was dependent on the concentration of Mg2+
(Figure 13) and could be eliminated entirely by EDTA.

The activity was also

dependent on the concentration of ATP (Figure 14), with a K/2 for ATP of approxi¬
mately 3

nM.

Although the kinase could use GTP as a substrate (K./, 10 /xM)

(Figure 14), it exhibited a preference for ATP. The kinase did not exhibit a pH op¬
timum; phosphorylation took place over a pH range from 5.5 to 8.0.

Phospho¬

rylation was not affected by the presence of the heat-stable CAPK inhibitor, CAPK
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FIGURE 10:
Autoradiograph showing endogenous phosphorylation in all
subcellular fractions.
Standard 1 min in vitro phosphorylation reactions were performed with and without
10
cAMP ( + /- cA) using protein samples from homogenate (HOM) and
subcellular fractions P0 through S3. Unstimulated (V) cells were treated with cimetidine 100 juM. Maximally stimulated (S) cells were treated with histamine (100 juM)
and forskolin (10/iM). Samples were resolved using SDS-PAGE and autoradio¬
graphy. Molecular weight standards are indicated on the left. Arrows show the
position of the 52 kDa phosphoprotein (pp52).

63

pp52 PHOSPHORYLATION

PI
_v s

S3
v s

f

►

fit*
flHi tfNQfc anp

CA-+-+

_

<pp52

-+- +

FIGURE 11: Autoradiograph showing endogenous phosphorylation in the apical
membrane fraction and the cytosolic fraction.
Standard 1 min in vitro phosphorylation reactions were performed with and without
10 mM cAMP ( + /- cA) using protein samples from the P, membrane fraction and
the cytosolic S3 fraction (S3). Unstimulated (V) cells were treated with cimetidine
(100 mM). Maximally stimulated (S) cells were treated with histamine (100 ^M) and
forskolin (10 mM). Samples were resolved using SDS-PAGE and autoradiography.
Arrows indicate the position of the 52 kDa phosphoprotein.
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FIGURE 12: Time course of po52 phosphorylation,
Standard in vitro phosphorylation reactions were performed using protein samples
from the maximally stimulated P, membrane fraction. Reactions were stopped at
time points from 5 sec to 300 sec. Samples were resolved by SDS-PAGE and
autoradiography, and phosphorylation of pp52 was quantified as described in
Chapter 3. Phosphorylation was maximal by 120 sec; therefore time points
beyond 120 sec are not shown.
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FIGURE 13: Magnesium dependence of pp52 phosphorylation.
Standard 1 min in vitro phosphorylation assays were performed using protein
samples from the maximally stimulated P, membrane fraction. However the
concentration of exogenous Mg2+ was varied from 0.1 mM to 30 mM. Samples
were resolved with SDS-PAGE and autoradiography, and the phosphorylation of
pp52 was quantified as described in Chapter 3. Phosphorylation is expressed here
as percent maximal phosphorylation. Phosphorylation was maximal at 10 mM;
therefore values for higher Mg*+ concentrations are not shown.
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FIGURE 14: ATP and GTP dependence of pp52 phosphorylation.
Standard 1 min. in vitro phosphorylation reactions were performed using protein
samples from the maximally stimulated P, membrane fraction. Either [gamma“Pj-ATP or [gamma-^PJ-GTP was used as a phosphate donor with concentrations
ranging from 0.1 *iM to 50 mM. Samples were resolved using 1-D SDS-PAGE and
autoradiography, and phosphorylation of pp52 was quantified as described in
Chapter 3. Phosphorylation is expressed here as percent maximal phosphoryla¬
tion. Closed circles represent the phosphorylation of pp52 in reactions using GTP.
Open squares represent the phosphorylation of pp52 in reactions using ATP.
Phosphorylation was negligible for concentrations of ATP and GTP less than 1 /iM;
these values are not shown.
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pseudosubstrate or CAPK catalytic subunit. This suggested that the kinase activity
was not dependent on CAPK. Calcium, calmodulin, manganese, and zinc also had
no effect on the phosphorylation of pp52.

Surprisingly, the addition of cAMP

decreased the phosphorylation of pp52 in a concentration-dependent fashion
(Figure 15). When cGMP was substituted for cAMP, this effect was not seen.
A 52 kDa protein was also noted to be phosphorylated in the cytosolic S3
fraction (Figure 11).

In contrast to the phosphorylation seen in the apical

membrane-rich P, fraction, this phosphorylation was observed in both stimulated
and unstimulated S3 fractions, but was more evident in the unstimulated samples.
This kinase activity also differed from that seen in the P, fraction in its cAMP
dependence. Whereas the apical membrane pp52 was phosphorylated in a cAMPindependent fashion and dephosphorylated in a cAMP-dependent manner, the
phosphorylation of the cytosolic pp52 required cAMP.

The heat-stable CAPK

inhibitor and CAPK pseudosubstrate inhibited phosphorylation of the cytosolic
pp52, suggesting that this activity was mediated by the catalytic subunit of CAPK.
The cytosolic activity also differed from the apical membrane activity in that there
was no evidence of endogenous dephosphorylation in the S3 fraction.

These

differences suggest either that histamine has different effects on the same protein
when it is found in different intracellular compartments or that the 52 kDa proteins
found in the membrane and cytosol are two different proteins.
The phosphorylation of the 52 kDa apical membrane protein in vitro
suggests that in vivo this protein is actually dephosphorylated by histamine
stimulation (Figure 16).

If histamine stimulation removes a phosphate from a
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FIGURE 15: The cAMP-dependent dephosphorvlation of pp52.
Standard 1 min in vitro phosphorylation reactions were performed in the presence
of cAMP (0.1 nM to 10 /xM) using protein samples from the maximally stimulated
P, membrane fraction. Samples were then resolved using SDS-PAGE and
autoradiography, and the phosphorylation of pp52 was quantified as described in
Chapter 3. Phosphorylation is expressed here as percent maximal phosphoryla¬
tion.

HISTAMINE

FIGURE 16: The relationship of phosphorylation changes in vivo to phosphoryla¬
tion changes observed in vitro.
In the resting parietal cell, protein A (gray square) is phosphorylated and protein
B (black circle) is not. Histamine stimulation causes the dephosphorylation of
protein A and the phosphorylation of protein B with endogenous phosphate (P).
The cells are then homogenized. Standard phosphorylation reactions as described
in Chapter 3 are performed on the homogenates. Only the dephosphorylated pro¬
tein A can undergo phosphorylation with the radioactively labelled phosphate (KP).
When the sample is resolved using SDS-PAGE and autoradiography, only protein
A is detected as a phosphoprotein. Thus the histamine-stimulated dephospho¬
rylation of protein A in vivo is detected as an increase in phosphorylation in vitro.
Conversely, an increase in phosphorylation in vivo is detected as a decrease in
vitro.
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protein, when homogenates are prepared and subjected to in vitro phosphoryl¬
ation, the empty phosphorylation site will be able to accept a phosphate group.
In contrast, a site that is already phosphorylated with native phosphate will not
undergo further phosphorylation with 32Pr

Thus the histamine-stimulated

dephosphorylation of a protein in vivo is detected as an increase in phosphoryla¬
tion in the homogenate.

Conversely, a histamine-stimulated increase in phos¬

phorylation in vivo is detected as a decrease in vitro.
The dephosphorylation of apical membrane pp52 observed in the presence
of cAMP was somewhat unexpected, since cAMP is known to activate CAPK and
thus protein phosphorylation. Further experiments demonstrated that the addition
of cAMP activated a phosphatase in the stimulated apical membrane fraction.
When cAMP was added to the reaction mixture at the end of the one minute
phosphorylation reaction, pp52 was completely dephosphorylated within two min¬
utes (Figure 17). This effect of cAMP was not inhibited by common phosphatase
inhibitors such as Zn2+, Mn2+, NaF and pyrophosphate. However it was inhibited
by the phosphatase inhibitor okadaic acid161 in a concentration-dependent fashion
(Figure 18). The ID^ for okadaic acid was approximately 0.3 jixM. This sensitivity
to okadaic acid is most consistent with a Type 1 phosphatase activity162.

IDENTIFICATION OF PP52
Several lines of investigation suggested that both the cytosolic and the
apical membrane forms of pp52 could be identified as the regulatory subunit of
Type II cAMP-dependent protein kinase (Rll). These included isoelectric focusing,
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FIGURE 17: Time course of cAMP-dependent deohosohorvlation of pp52 in the
stimulated apical membrane fraction.
Standard 1 min in vitro protein phosphorylation reactions were performed using
protein samples from the maximally stimulated P, membrane fraction. At the end
of one min 10 mM EDTA was added to stop further phosphorylation. Reactions
were then allowed to continue for 0 to 240 sec more in the presence or absence
of 10 mM cAMP. Samples were then resolved using SDS-PAGE and autoradio¬
graphy and the phosphorylation of pp52 was quantified as described in Chapter
3. Phosphorylation is expressed as percent maximal phosphorylation. The time
points indicated above were measured from the end of the 1 min reaction. Open
squares represent the phosphorylation of pp52 in the absence of cAMP. Closed
circles represent the phosphorylation of pp52 in the presence of cAMP. Beyond
120 sec there was no detectable phosphorylation of pp52 in the presence of
cAMP; therefore this data is not shown.
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FIGURE 18: Autoradiograph showing the effect of the phosphatase inhibitor
okadaic acid on the cAMP-deoendent deohosphorvlation of pp52.
Standard 1 min in vitro phosphorylation reactions were performed using protein
samples from the maximally stimulated P, fraction. At one min 10 mM EDTA was
added to stop further phosphorylation. At that time CAMP (10 /uM) and okadaic
acid (1 nM to 10 /xM) were added to the reactions, which were allowed to proceed
for 3 min more. Samples were then resolved using SDS-PAGE and autoradio¬
graphy. cA + /- indicates the presence/absence of 10 mM cAMP. The concen¬
tration of okadaic acid in each sample is indicated at the top of each lane. The
arrow labelled Rll marks the location of pp52.
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phosphoamino acid analysis, cAMP-binding, and immunoreactivity. Two-dimen¬
sional gel electrophoresis showed that both the membrane and cytosolic forms of
pp52 had isoelectric points of approximately 5.0 (Figure 19), comparable to
published values for Rif63 139. Phosphoamino acid analysis of the membrane and
cytosolic forms of pp52 was also consistent with the conclusion that these proteins
are both Rll. While Rll can be phosphorylated at several sites, the only amino
acids that are phosphorylated are serine residues. Similarly, phosphoamino acid
analysis showed that pp52 in both membrane and cytosol is phosphorylated on
serine residues.
Both forms of pp52 were found to be cAMP-binding proteins. Mammalian
cells are believed to contain only two cAMP-binding proteins:

the regulatory

subunits of Type I and Type II CAPK164. 8-azido-[32P]-cAMP binding was used to
assay subcellular fractions for cAMP-binding proteins.

The P, and S3 fractions

each contained two major cAMP-binding proteins (Figure 20).

The first, which

focused as a doublet of approximately 49 kDa, was identified as Rl on the basis
of its electrophoretic mobility. Maximal stimulation of parietal cells with histamine
and forskolin abolished 8-azido-cAMP binding to this protein.

This finding is

consistent with results published by Chew71, who interpreted it as evidence for the
stimulation of Type I CAPK.

Since the secretagogues induce an increase in

intracellular cAMP, this endogenous cAMP is presumably bound to Rl, thus
preventing 8-azido-cAMP binding and liberating free catalytic subunit.

Both P,

and S3 also contained cAMP-binding proteins with molecular weights of 52 kDa.
Since the molecular weights, as determined by SDS-PAGE, and the isoelectric
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FIGURE 19: Autoradiograph of a two-dimensional ael showing protein phosphory¬
lation in stimulated apical membrane and unstimulated cytosolic fractions.
Standard 1 min in vitro phosphorylation reactions were performed using protein
samples from maximally stimulated apical membrane fractions (SP,) and
unstimulated cytosolic fractions (VS3). The phosphorylated samples were then
resolved using 2-D gel electrophoresis and autoradiography. Isoelectric focusing
was performed in the horizontal dimension; ( + ) and (-) indicate the acidic and
basic ends of the gels. SDS-PAGE was performed in the vertical direction. Arrows
mark the positions of the 52 kDa phosphoproteins detected in both fractions
Carbamylated isoelectric focusing standards on the original gel (not shown here,
were used to calculate the isoelectric points of these proteins.
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FIGURE 20: Autoradiograph of a two-dimensional gel showing cAMP-binding
proteins in apical membrane and cytosolic fractions.
Samples from maximally stimulated (S) and unstimulated (V) P, apical membrane
and S3 cytosolic fractions were labeled with 8-azido-[32P]-cAMP as described in
Chapter 3. The labeled samples were then resolved using 2-D gel electrophoresis
and autoradiography. Isoelectric focusing (IEF) was performed in the horizontal
direction; (+) and (-) denote the acidic and basic ends of the gels. SDS-PAGE
was performed in the vertical direction. Arrows mark the positions of the 49 kDa
cAMP-binding protein thought to be the regulatory subunit of Type I CAPK (Rl) and
the 52 kDa cAMP-binding protein thought to be the regulatory subunit of Type II
CAPK (Rll).
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points, as determined by two-dimensional gel electrophoresis, were identical with
those of the 52 kDa phosphoproteins, it was assumed that the cAMP-binding
proteins were in fact the same 52 kDa proteins. The sizes and isoelectric points
of these cAMP-binding proteins also agreed with published values for Rll.
However the distribution of the 49 and 52 kDa cAMP-binding proteins varied
between the two subcellular fractions.

The smaller cAMP-binding protein

predominated in S3, while the 52 kDa protein was more prominant in the P,
fraction.

Thus it was inferred that Rl was the major cAMP-binding protein in

cytosol, while Rll predominated in the apical membrane fraction.
In stimulated cells, the 52 kDa protein also displayed different patterns of
cAMP-binding in the two fractions. In the cytosolic fraction, it behaved much like
the 49 kDa protein in that stimulation decreased its 8-azido-cAMP binding. In con¬
trast, in the membrane fraction, stimulation had no effect on the cAMP binding to
the 52 kDa protein.
Both forms of pp52 were immunoprecipitated by polyclonal antisera raised
against rat heart Rll and rat brain Rll (Figure 21). However these antisera showed
different patterns of immunoreactivity against the membrane and the cytosolic
forms of pp52. The antisera against both heart Rll and brain Rll recognized the
cytosolic pp52 equally well.

In contrast, the membrane pp52 showed a greater

affinity for the antibody against brain Rll. From these data, it was concluded that
the membrane and the cytosolic forms of pp52 were two different subtypes of Rll,
the membrane pp52 being more like the neural subtype. This conclusion might
explain the fact that phosphorylation of membrane pp52 is independent of cAMP,
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FIGURE 21: Autoradiograph showing immunoprecipitation of pp52 with antibodies
against the regulatory subunit of Type II cAMP-deoendent protein kinase.
Samples from maximally stimulated apical membrane fractions (SP') and
unstimulated cytosolic fractions (VS3) were phosphorylated using the standard 1
min in vitro phosphorylation reaction. The phosphorylated samples were then
incubated with polyclonal antisera against rat heart Rll (H) and rat brain Rll (B).
Controls were incubated with non-immune rabbit serum (N). After immunoprecipi¬
tation as described in Chapter 3, samples were resolved using SDS-PAGE and
autoradiography. Arrows indicate pp52.
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whereas phosphorylation of cytosolic pp52 is enhanced in the presence of cAMP.

PARIETAL CELL SECRETION STUDIES
Since okadaic acid, a phosphatase inhibitor, prevented the cAMP-dependent
dephosphorylation of membrane pp52, the effects of okadaic acid on parietal cell
secretion were investigated. Parietal cells were preincubated with okadaic acid for
30 min before the addition of 10 /xM histamine. [14C]aminopyrine uptake was used
to measure parietal cell acid sequestration, an indirect measure of acid secretion.
Okadaic acid alone had no effect on either basal AP uptake or basal levels of
intracellular cAMP. However the phosphatase inhibitor caused a dose-dependent
decrease in histamine-stimulated AP accumulation (Figure 22). In the presence of
3 /xM okadaic acid, histamine-stimulated AP uptake was decreased by 70 %. A
similar effect was seen in cells stimulated with 10 /xM forskolin and 100 /xM
histamine, the combination used to maximally stimulate the cells used for
subcellular fractionation. To determine whether this effect was mediated by cAMP,
cAMP was measured in histamine-stimulated cells. The presence of 3 *xM okadaic
acid had no effect on the histamine-stimulated increase in cAMP (Figure 23).
These data suggested that a protein phosphatase may play a critical role in parietal
cell acid secretion.
Additional studies of parietal cell acid secretion were undertaken in the
presence of H-8, an inhibitor of cAMP dependent protein kinase with a

of 1.2

mM165. H-8 did not inhibit histamine-stimulated AP uptake at concentrations ranging
from 0.1 /xM to 30 /iM (Figure 24).

This suggested that, contrary to previous
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FIGURE 22: The effect of the phosphatase inhibitor okadaic acid on histaminestimulated [14C]aminopvrine uptake.
Histamine-stimulated [,4C]aminopyrine ([14C]AP) uptake was measured in the
presence of the phosphatase inhibitor okadaic acid (OA). [14C]AP uptake was
measured as described in Chapter 3 and is expressed here as percent maximal
uptake ± SEM (n = 4). Maximal uptake was determined in the presence of
histamine (10 ^M) alone. [,4C]AP uptake was determined for okadaic acid
concentrations from 10 nM to 3 mM. The concentration of histamine was 10 /xM
for all conditions.
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FIGURE 23: The effect of the phosphatase inhibitor okadaic acid on the
histamine-stimulated increase in cAMP.
The cellular cAMP content of isolated rabbit parietal cells was measured in the
presence and absence of the phosphatase inhibitor okadaic acid (3 mM) as
described in Chapter 3. Cellular cAMP content was expressed as pmol/million
cells ± SEM (n=4). cAMP levels were measured in unstimulated cells (US), cells
stimulated with 1 /xM histamine, and cells stimulated with 10 mM histamine. White
bars represent the cAMP content of cells in the absence of okadaic acid; dark bars
represent the cAMP content of cells in the presence of okadaic acid.
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FIGURE 24: The effect of the CAPK inhibitor H-8 on histamine-stimulated
[14C]aminopvrine uptake.
Histamine-stimulated [,4C]aminopyrine (f4C]AP) uptake in isolated rabbit parietal
cells was measured in the presence and absence of the cAMP-dependent kinase
inhibitor H-8. [,4C]AP uptake was measured as described in Chapter 3 and is
expressed here as percent maximal uptake ± SEM (n=4). Maximal uptake was
determined in the presence of histamine (10 ^M) alone The open circle shows
[14C]AP uptake in the presence of histamine (10 mM) alone. The closed circles
show the effect of H-8 (10 nM to 30 mM) on histamine (10 MM)-stimulated [14C]AP
uptake.
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assumptions, activation of CAPK might not be an integral step in histaminestimulated acid secretion.
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CHAPTER 5
DISCUSSION
HISTAMINE-STIMULATED ACID SECRETION: THE CLASSICAL MODEL
Previous work in the parietal cell has assumed that the histamine-stimulated
increase in acid secretion was mediated by the cAMP-dependent protein kinase
(Figure 25 ) 69 70,71,72'73'74'75. Histamine elicited a sustained increase in the intracellular
cAMP concentration of the parietal cell36,37. Histamine also activated parietal cell
CAPK67 68 69 70,71. These data led to the assumption that CAPK mediated histaminestimulated acid secretion, presumably by phosphorylating key protein inter¬
mediates.

HISTAMINE-STIMULATED ACID SECRETION: A NEW MODEL
The data presented here suggest that while secretion still appears to be
mediated by cAMP, the cyclic nucleotide does not act solely via CAPK, since the
addition of the CAPK inhibitor H-8 to whole parietal cells did not affect acid
secretion. At least one other investigator has reported a similar finding, in which
cAMP-dependent exocytosis did not appear to be mediated by CAPK".
Our data demonstrate that histamine stimulation of rabbit parietal cells
affects the phosphorylation state of a 52 kDa protein that is found in the apical
membrane-rich fraction.

Both kinase and phosphatase activities in this fraction

have been characterized. Furthermore, the 52 kDa substrate has been identified
as the neural subtype of the regulatory subunit of Type II CAPK. Okadaic acid, a
phosphatase inhibitor, inhibits both the dephosphorylation of this protein and the

FIGURE 25: Histamine-stimulated acid secretion: the classical model.
1) In the resting cell, cAMP-dependent kinase (CAPK) is found in the inactive form.
2) Histamine stimulation increases the intracellular concentration of cAMP. 3)
CAMP binds to the regulatory subunit of CAPK, releasing active catalytic subunit.
4) The free catalytic subunit phosphorylates protein X. 5) The phosphorylated
protein acts as an intermediary in histamine-stimulated acid secretion. H histamine; H2 - type 2 histamine receptor; C - catalytic subunit of CAPK; X - a pro¬
tein; X-P - the phosphorylated form of the protein.
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secretion of acid by the parietal cell. This suggests that a phosphatase plays a
key role in histamine-stimulated acid secretion.
These data have led us to propose a new mode! for histamine-stimulated
parietal cell acid secretion (Figure 26). 1) In the resting state, Rll is phosphorylated
by a kinase that has not yet been identified. 2) Histamine stimulation increases the
concentration of intracellular cAMP. 3) Cylic AMP binds to apical membrane Rll,
changing its conformation. 4) This change in conformation makes a phosphate
group accessible to an apical membrane phosphatase that dephosphorylates Rll.
5) The dephosphorylated Rll promotes acid secretion by an unknown mechanism.
It is possible that cAMP directly or indirectly acts on the phosphatase rather
than the substrate. However since Rll is known to be a cAMP-binding protein it
is more likely that the effect of cAMP is substrate-mediated.

The physiological

role of this phosphorylation change is not yet known. Since previous data have
shown Rll to be associated with cytoskeletal elements'43 146, Rll may influence the
cytoskeletal changes associated with parietal cell acid secretion21 22,23.

The

dephosphorylation of apical membrane Rll may activate CAPK and directly or in¬
directly cause the phosphorylation of cytoskeletal elements.

However other

investigators have found that Type II CAPK is not activated in histamine-stimulated
parietal cells71. It is therefore possible that the apical membrane Rll interacts with
the cytoskeleton through a function other than its regulation of CAPK.
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FIGURE 26: Histamine-stimulated acid secretion: a new mndPl
1) In the resting state, a membrane-bound kinase phosphorylates the apical
membrane Rll. 2) Histamine stimulation increases the intracellular concentration
of cAMP. 3) cAMP binds to Rll, changing its conformation. 4) This change in
conformation makes the phosphate group accessible to an apical membrane
phosphatase. 5) The dephosphorylated Rll acts as an intermediary in histaminestimulated acid secretion. H - histamine; H2 - type 2 histamine receptor’ P phosphate.
’
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Identification of the phosphatase
Several phosphatases have been reported to cause the cAMP-dependent
dephosphorylation of rh166 127 124133 167 These generally require cAMP concentrations
between 4 and 25 mM, close to the concentration used in our experiments.
However our data characterizing the apical membrane phosphatase activity differed
from previously published reports, suggesting that there may be more than one
cAMP-dependent phosphatase that acts on Rll.

Most of the cAMP-dependent

phosphatases described in the literature are inhibited by phosphatase inhibitors
such as NaF and ZnCI2.

These agents did not affect the activity of the apical

membrane phosphatase in our preparation.
differences in the substrate.

This difference may also reflect

In at least one instance, the phosphatase was

probably acting on the non-neural form of Rll, since dephosphorylation altered its
electrophoretic mobility133.

In contrast, our data suggest that the phosphatase

substrate in the apical membrane fraction is probably the neural form of Rll.
While most of the phosphatases that have been reported to act on Rll show
cAMP dependence, Blumenthal et aL have described an interesting calmodulindependent phosphatase that catalyzes the removal of a phosphate group from the
autophosphorylated serine-95 of Rll168.

This phosphatase, also known as

calcineurin, has been reported to bind tightly to Type II CAPK from brain via the
regulatory subunit169. As mentioned earlier, Rll is known to interact with proteins
other than the regulatory subunit of CAPK143 144 145. It is unlikely that this phospha¬
tase is the same as that identified in the apical membrane fraction of stimulated
parietal cells.

The calmodulin-dependent phosphatase activity was completely
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inhibited by 2 mM EDTA, whereas the dephosphorylation of Rll in the apical
membrane was completely unaffected by the addition of 10 mM EDTA.
Although there are no other reports of histamine-stimulated phosphatases
in the parietal ceii, Im et aL have identified a phosphatase in membranes prepared
from the stomachs of carbachol-injected rats170. Like the P, fraction used in our
experiments this membrane preparation was enriched in the H+/K+-ATPase.
However unlike the histamine-stimulated phosphatase described here, the carbachol-stimulated phosphatase was inhibited by NaF, ZnCI2, and pyrophosphate.
The carbachol- and histamine-stimulated phosphatase activities are therefore
unlikely to be the result of the same enzyme.
Although a number of phosphatases that act on Rll have been described,
most of these descriptions are not compatible with the data from the rabbit parietal
cell.

This may reflect the fact that these phosphatases act on a different

phosphorylation site and/or subtype of Rll. However Kiss et aL have identified a
CAPK catalytic subunit-independent kinase and a cAMP-dependent phosphatase
that act on Rll in rat liver membranes. These appear to be similar to the activities
seen in parietal cell membranes134. The addition of NaF did not inhibit phospha¬
tase activity in either preparation. Furthermore, in both cases the site of phos¬
phorylation and dephosphorylation appeared to be a site other than the autophos¬
phorylation site of Rll.
Several pieces of evidence support the conclusion that the phosphorylation
site of interest on apical membrane Rll is not the autophosphorylation site. First,
the autophosphorylation of serine-95 has a Ky? for ATP of approximately 0.4 /iM123.

89
The phosphorylation of the apical membrane Rll has a K/2 that is approximately
tenfold higher. Second, the addition of CAPK catalytic subunit does not increase
the phosphorylation of the site on the apical membrane Rll, as would be expected
if it were the autophosphorylation site. Other sites on Rll that are known to be
phosphorylated are the serines-44 and-47 phosphorylated by glycogen synthase
kinase 3 (GSK 3)128, and the serines-74 and -76 phosphorylated by casein kinase
II (CK II)129. However immunoprecipitation with antibodies against heart and brain
Rll has shown that the apical membrane Rll more closely resembles the neural
form of Rll, which does not possess the consensus sequence for phosphorylation
by GSK 3142. While it is possible that the apical membrane Rll is phosphorylated
at a site that has not been previously described, the data also support the
possibility that the apical membrane Rll is phosphorylated and dephosphorylated
at the CK II site.
The phosphatase activity seen in apical membranes from stimulated rabbit
parietal cells therefore seems to be a type I phosphatase that removes a
phosphate group from the CK II site of Rll. Like the activity described by Kiss et
aL170, this phosphatase is dependent on cAMP but not inhibited by NaF.

Identification of the kinase
In the resting state, the apical membrane Rll presumably returns to the
phosphorylated state. It is not known which kinase mediates this reaction. The
catalytic subunit of CAPK is unlikely to be responsible, since it is thought to
phosphorylate only serine-95. It is possible that CK II phosphorylates the apical
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membrane Rll.

CK II is a ubiquitous protein kinase found in many different

organisms and species171.

Despite its widespread occurrence and ability to

phosphorylate a number of different substrates in vitro, it has as yet no known
physiological substrates. The kinase that phosphorylates the apical membrane Rll
exhibits several features that make CK II a likely candidate. Like CK II, the apicai
membrane Rll kinase is able to use both ATP and GTP as phosphate donors but
has a greater affinity for ATP172. Furthermore, both kinases are also active over a
wide pH range. While these data do not conclusively identify the apical membrane
Rll kinase, it is possible that Rll will be the first substrate reported to be phosphorylated by CK II under physiological conditions.

Other forms of Rll in the parietal cell
The form of Rll identified in the cytoplasm of rabbit parietal cells does not
appear to be a substrate for the kinase and phosphatase that act on the apical
membrane Rll. Based on their immunoreactivity, we have hypothesized that the
membrane Rll and the cytosolic Rll are two different subtypes of Rll. The former
appears to resemble the neural form, while the latter is probably closer to the nonneural variety. This hypothesis might explain why histamine stimulation of rabbit
parietal cells affects the membrane and cytosolic forms of Rll differently.

An

analogous situation has been observed in Friend erythroleukemic cells137. When
these cells were stimulated to differentiate, one form of Rll increased while the
other was unaffected. This difference in response may reflect modifications to the
two forms of Rll that make them react differently to stimuli. However it may also
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reflect the subcellular distribution of Rll subtypes. The different forms of Rll may
be found in separate intracellular compartments, and individual stimuli may exert
their effects only at selected locations within the cell.

CONCLUSION
The data presented here support a new model for histamine-stimulated
parietal cell acid secretion in which the phosphorylation state of a neural-type Rll
in the apical membrane plays a critical role. Whole cell secretion data indicate that
a phosphatase activity is essential to histamine-stimulated acid secretion.
Histamine stimulation of isolated rabbit parietal cells appears to activate a mem¬
brane-associated type 1 phosphatase that dephosphorylates the apical membrane
Rll.

The apical membrane also contains a kinase that phosphorylates the

membrane-associated Rll. The data indicate that this kinase may be casein kinase
II. While the phosphorylation site of the apical membrane Rll has not been conclu¬
sively identified, the data suggest that this may be the site phosphorylated by
casein kinase II in vitro. The parietal cell also contains a cytosolic form of Rll that
is not a substrate for the histamine-stimulated apical membrane phosphatase. The
cytosolic Rll appears to resemble the non-neural subtype of Rll.

FUTURE DIRECTIONS
While this work provides some insight into the molecular mechanism of acid
secretion, a number of key questions remain to be answered.

First, it must be

conclusively demonstrated in whole cell experiments that histamine stimulation
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leads to the dephosphorylation of Rll. Second, the Rll subtypes in the parietal cell
must be purified and characterized.

Third, the phosphorylation site on apical

membrane Rli needs to be specifically identified and its biochemical function under¬
stood. Fourth, the apical membrane kinase and phosphatase must be purified and
identified.

Fifth, it must be determined whether apical membrane Rll exerts its

effects through CAPK or whether it is associated with other effector proteins. Last¬
ly, it must be seen whether other secretagogues that promote acid secretion, such
as carbachol and gastrin, are also able to affect the phosphorylation state of Rll.
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